{"content":"<li class=\"n-box-item date-title\" data-end=\"1518757199\" data-start=\"1518670800\" data-txt=\"Monday, December 23, 2019\">Thursday, February 15, 2018</li><li class=\"n-box-item sa-box-item\" data-id=\"3331756\" data-ts=\"1518742476\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INST\" target=\"_blank\">INST</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331756-instructureminus-6_4-after-launching-2_3m-share-offering-discount\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Instructure -6.4% after launching 2.3M-share offering at discount</a></h4><ul>   <li>Instructure (NYSE:<a href='https://seekingalpha.com/symbol/INST' title='Instructure'>INST</a>) is <font color='red'>6.4% lower</font> after hours following news that it will seek a <a href=\"https://seekingalpha.com/pr/17076811-instructure-announces-public-offering-common-stock\" target=\"_blank\">public offering of 2.3M shares</a>.</li>    <li>The shares are said to be offered at $39-$40 each, Bloomberg reports -- a 2.9%-5.3% discount vs. today's close of $41.20. Shares are quoting at $38.55 after hours.</li>    <li>All shares to be sold are being sold by the company. Underwriters will have a 30-day option to buy up to an additional 345,000 shares.</li>    <li>Net proceeds are set for general purposes.</li>    <li>Morgan Stanley and Credit Suisse are book-running managers.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3331756\" data-linked=\"Instructure -6.4% after launching 2.3M-share offering at discount\" data-tweet=\"$INST - Instructure -6.4% after launching 2.3M-share offering at discount https://seekingalpha.com/news/3331756-instructureminus-6_4-after-launching-2_3m-share-offering-discount?source=tweet\" data-url=\"https://seekingalpha.com/news/3331756-instructureminus-6_4-after-launching-2_3m-share-offering-discount\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:54 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331755\" data-ts=\"1518742023\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GOOG\" target=\"_blank\">GOOG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331755-google-buying-iot-platform-xively-from-logmein-for-50m\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Google buying IoT platform Xively from LogMeIn for $50M</a></h4><ul>     <li>Google (<a href='https://seekingalpha.com/symbol/GOOG' title='Alphabet, Inc. Cl C'>GOOG</a>, <a href='https://seekingalpha.com/symbol/GOOGL' title='Alphabet, Inc. Cl A'>GOOGL</a>) says it will <a href=\"https://techcrunch.com/2018/02/15/google-to-acquire-xively-iot-platform-from-logmein/\" target=\"_blank\">buy Xively</a>, an established Internet-of-Things platform, from LogMeIn (NASDAQ:<a href='https://seekingalpha.com/symbol/LOGM' title='LogMeIn, Inc.'>LOGM</a>) for $50M.</li>    <li>LogMeIn is <font color='red'>off 7.7%</font> after hours; <a href='https://seekingalpha.com/symbol/GOOG' title='Alphabet, Inc. Cl C'>GOOG</a> <font color='green'>+0.1%</font>; <a href='https://seekingalpha.com/symbol/GOOGL' title='Alphabet, Inc. Cl A'>GOOGL</a> <font color='green'>+0.2%</font>.</li><li>The move will accelerate Google Cloud's move into the IoT market, which it says will reach 20B connected devices by 2020.</li>     <li>Meanwhile, LogMeIn is getting out of the area: \"Does this mean LogMeIn is exiting the IoT? Well, if you mean the IoT connectivity platform space, yes, we&rsquo;re leaving it. We believe that Google Cloud, now armed with Xively&rsquo;s team and great technology &ndash; and backed by their platform and developer heritage and reach &ndash; are a far better fit for the future of platform leadership,&rdquo; the company says.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3331755\" data-linked=\"Google buying IoT platform Xively from LogMeIn for $50M\" data-tweet=\"$GOOG $GOOG $GOOGL - Google buying IoT platform Xively from LogMeIn for $50M https://seekingalpha.com/news/3331755-google-buying-iot-platform-xively-from-logmein-for-50m?source=tweet\" data-url=\"https://seekingalpha.com/news/3331755-google-buying-iot-platform-xively-from-logmein-for-50m\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:47 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331753\" data-ts=\"1518740632\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MCHX\" target=\"_blank\">MCHX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331753-marchex-down-after-trimming-losses-in-q4\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Marchex down after trimming losses in Q4</a></h4><ul>   <li>Marchex (NASDAQ:<a href='https://seekingalpha.com/symbol/MCHX' title='Marchex, Inc.'>MCHX</a>) <font color='red'>fell 2.9%</font> after hours after its <a href=\"https://seekingalpha.com/news/3331659-marchex-beats-0_01-beats-revenue\" target=\"_blank\">Q4 report</a> where it trimmed losses substantially and swung to a gain on an adjusted basis.</li>    <li>The company beat expectations (one estimate) for profits and revenues, with headline net loss coming to $841,000 vs. a year-ago loss of $5.7M.</li>    <li>On a non-GAAP basis, EPS was $0.01 vs. a year-ago -$0.04.</li>    <li>For Q1, it's guiding to revenue of $21M or more (vs. one estimate for $25.3M) and EBITDA of break-even of better (vs. estimate for $0.3M).</li>    <li><a href=\"https://seekingalpha.com/pr/17076790-marchex-announces-fourth-quarter-full-year-2017-results\" target=\"_blank\">Press release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3331753\" data-linked=\"Marchex down after trimming losses in Q4\" data-tweet=\"$MCHX - Marchex down after trimming losses in Q4 https://seekingalpha.com/news/3331753-marchex-down-after-trimming-losses-in-q4?source=tweet\" data-url=\"https://seekingalpha.com/news/3331753-marchex-down-after-trimming-losses-in-q4\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:23 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331751\" data-ts=\"1518739673\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TPC\" target=\"_blank\">TPC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331751-tutor-perini-led-jv-wins-1_4b-contract-to-rebuild-newark-airport\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tutor Perini-led JV wins $1.4B contract to rebuild Newark airport</a></h4><ul>     <li>Tutor Perini (NYSE:<a href='https://seekingalpha.com/symbol/TPC' title='Tutor Perini Corporation'>TPC</a>) <font color='green'>+1.9%</font> after-hours on news that the Port Authority of New York and New Jersey <a href=\"https://seekingalpha.com/pr/17076962-tutor-perini-announces-1_41-billion-newark-airport-terminal-one-design-build-project\" target=\"_blank\">awarded a contract valued at $1.4B</a> to its joint venture for the 1M sq. ft. Newark Airport Terminal One Design-Build Project.</li>     <li>The project will be the largest transportation infrastructure design-build contract in New Jersey's history.</li>     <li>TPC says work on the project is expected to begin this April and substantial completion is anticipated in 2022.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3331751\" data-linked=\"Tutor Perini-led JV wins $1.4B contract to rebuild Newark airport\" data-tweet=\"$TPC - Tutor Perini-led JV wins $1.4B contract to rebuild Newark airport https://seekingalpha.com/news/3331751-tutor-perini-led-jv-wins-1_4b-contract-to-rebuild-newark-airport?source=tweet\" data-url=\"https://seekingalpha.com/news/3331751-tutor-perini-led-jv-wins-1_4b-contract-to-rebuild-newark-airport\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:07 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331744\" data-ts=\"1518736976\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GOGO\" target=\"_blank\">GOGO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331744-gogo-rises-william-blair-eyes-prospect-of-short-squeeze\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gogo rises as William Blair eyes prospect of short squeeze</a></h4><ul>   <li>Gogo (NASDAQ:<a href='https://seekingalpha.com/symbol/GOGO' title='Gogo'>GOGO</a>) <font color='green'>jumped 7.9%</font> today, erasing February declines, after a note from William Blair hinted at potential for a short squeeze.</li>    <li>Sentiment is too negative, analyst Louie DiPalma wrote, and it's set for a rebound or squeeze (considering short interest is 25% higher than when the stock was at an all-time low in 2016) in conjunction with earnings next week. (h/t Bloomberg)</li>    <li>The company doesn't have to do anything \"extraordinary\" to trade into the $20s next year other than install ilts backlog and keep riding trends, he says.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3331744\" data-linked=\"Gogo rises as William Blair eyes prospect of short squeeze\" data-tweet=\"$GOGO - Gogo rises as William Blair eyes prospect of short squeeze https://seekingalpha.com/news/3331744-gogo-rises-william-blair-eyes-prospect-of-short-squeeze?source=tweet\" data-url=\"https://seekingalpha.com/news/3331744-gogo-rises-william-blair-eyes-prospect-of-short-squeeze\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:22 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331735\" data-ts=\"1518734174\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SNCR\" target=\"_blank\">SNCR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331735-after-hours-gainers-losers-2-15-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers (2/15/2018)</a></h4><ul>     <li><b>Top gainers:</b> <a href='https://seekingalpha.com/symbol/SNCR' title='Synchronoss Technologies, Inc.'>SNCR</a> <font color='green'>+28.3%</font>. <a href='https://seekingalpha.com/symbol/CDLX' title='Cardlytics, Inc.'>CDLX</a> <font color='green'>+17.5%</font>. <a href='https://seekingalpha.com/symbol/TNDM' title='Tandem Diabetes Care, Inc.'>TNDM</a> <font color='green'>+7.9%</font>. <a href='https://seekingalpha.com/symbol/SJM' title='J. M. Smucker Company'>SJM</a> <font color='green'>+3.5%</font>. <a href='https://seekingalpha.com/symbol/MULE' title='MuleSoft'>MULE</a> <font color='green'>+1.6%</font>.</li><li><b>Top losers:</b> <a href='https://seekingalpha.com/symbol/COHU' title='Cohu, Inc.'>COHU</a> <font color='red'>-17.0%</font>. <a href='https://seekingalpha.com/symbol/ANET' title='Arista Networks, Inc.'>ANET</a> <font color='red'>-16.0%</font>. <a href='https://seekingalpha.com/symbol/PCRX' title='Pacira Pharmaceuticals, Inc.'>PCRX</a> <font color='red'>-13.7%</font>. <a href='https://seekingalpha.com/symbol/CGNX' title='Cognex Corporation'>CGNX</a> <font color='red'>-11.5%</font>. <a href='https://seekingalpha.com/symbol/PI' title='Impinj, Inc.'>PI</a> <font color='red'>-8.2%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3331735\" data-linked=\"After Hours Gainers / Losers (2/15/2018)\" data-tweet=\"$SNCR $SNCR $CDLX - After Hours Gainers / Losers (2/15/2018) https://seekingalpha.com/news/3331735-after-hours-gainers-losers-2-15-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3331735-after-hours-gainers-losers-2-15-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:36 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331731\" data-ts=\"1518733686\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IO\" target=\"_blank\">IO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331731-ion-geophysical-to-launch-public-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ION Geophysical to launch public offering</a></h4><ul>     <li>ION Geophysical (NYSE:<a href='https://seekingalpha.com/symbol/IO' title='ION Geophysical Corporation'>IO</a>) <font color='red'>-8%</font> after-hours following news it plans a <a href=\"https://seekingalpha.com/pr/17076914-ion-announces-proposed-public-offering-common-stock-warrants\" target=\"_blank\">public offering</a> of common stock and warrants, with a probable underwriters option to purchase additional shares and warrants.</li><li>The size and specific purpose of the offering is not yet disclosed.</li><li>IO shares have surged more than 50% since issuing <a href=\"https://seekingalpha.com/news/3329099-ion-geophysical-beats-0_43-beats-revenue\" target=\"_blank\">strong Q4 results</a> after the close on Feb. 7.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3331731\" data-linked=\"ION Geophysical to launch public offering\" data-tweet=\"$IO - ION Geophysical to launch public offering https://seekingalpha.com/news/3331731-ion-geophysical-to-launch-public-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3331731-ion-geophysical-to-launch-public-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:28 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331728\" data-ts=\"1518732770\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FLS\" target=\"_blank\">FLS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331728-flowserve-falls-4-after-q4-earnings-miss-downside-2018-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Flowserve falls 4% after Q4 earnings miss, downside 2018 guidance</a></h4><ul>     <li>Flowserve (NYSE:<a href='https://seekingalpha.com/symbol/FLS' title='Flowserve Corporation'>FLS</a>) <font color='red'>-4.1%</font> after-hours as it narrowly misses <a href=\"https://seekingalpha.com/news/3331679-flowserve-misses-0_01-revenue-line\" target=\"_blank\">Q4 earnings</a> expectations while guiding 2018 earnings below consensus.</li>     <li>FLS says Q4 profit fell to $65.8M, or $0.50/share, from $89.6M, or $0.68/share, in last year's Q4, and Q4 revenues slipped 3.4% (7.1% on a constant currency basis) to $1.03B.</li>     <li>Q4 bookings totaled $985M, up 8.5% Y/Y (4.7% on a constant currency basis), resulting in a year-end 2017 backlog of $2.03B, up 6.9% Y/Y.</li>     <li>FLS issues mixed guidance for FY 2018, seeing EPS of $1.50-$1.70 vs. $1.85 analyst consensus estimate and revenue growth of 3%-6%, which should result in total revenues of $3.77B-$3.88B vs. $3.74B consensus.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3331728\" data-linked=\"Flowserve falls 4% after Q4 earnings miss, downside 2018 guidance\" data-tweet=\"$FLS - Flowserve falls 4% after Q4 earnings miss, downside 2018 guidance https://seekingalpha.com/news/3331728-flowserve-falls-4-after-q4-earnings-miss-downside-2018-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3331728-flowserve-falls-4-after-q4-earnings-miss-downside-2018-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:12 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331720\" data-ts=\"1518732040\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PI\" target=\"_blank\">PI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331720-impinjminus-7_3-after-q4-misses-soft-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Impinj -7.3% after Q4 misses, soft guidance</a></h4><ul><li>        Impinj (NASDAQ:<a href='https://seekingalpha.com/symbol/PI' title='Impinj, Inc.'>PI</a>) shares are&nbsp;<font color='red'>down 7.3%</font>&nbsp;aftermarket following Q4 results that missed EPS and revenue estimates.</li><li>                  Q1 guidance: Revenue, $23.25M to $25.25M (was: $20M to $22M; consensus: $21.22M); EPS, -$0.42 to -$0.35 (consensus: -$0.34).    </li><li>               Management comment (CEO Chris Diorio): \"As we announced earlier this month, we anticipate softness in our first-quarter 2018 endpoint IC volumes and revenue due to shortened lead times contributing to a reduction in our order backlog, as well as ongoing reductions in inlay-partner inventory. We remain confident in our market opportunity, position, and in our vision of identifying, locating and authenticating every item in our everyday world, and connecting every one of those items to the cloud.\"&nbsp;</li><li>               Earnings call is scheduled for 5 PM Eastern Time with a webcast available <a href=\"http://investor.impinj.com/phoenix.zhtml?c=246148&amp;p=irol-irhome\" target=\"_blank\">here</a>.&nbsp;</li><li>               <a href=\"https://seekingalpha.com/pr/17076777-impinj-announces-fourth-quarter-full-year-2017-financial-results\" target=\"_blank\">Press release</a>&nbsp;&nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3331660-impinj-misses-0_09-misses-revenue\" target=\"_blank\">Impinj misses by $0.09, misses on revenue</a> (Feb. 15)</li></ul><div class=\"tiny-share-widget\" data-id=\"3331720\" data-linked=\"Impinj -7.3% after Q4 misses, soft guidance\" data-tweet=\"$PI - Impinj -7.3% after Q4 misses, soft guidance https://seekingalpha.com/news/3331720-impinjminus-7_3-after-q4-misses-soft-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3331720-impinjminus-7_3-after-q4-misses-soft-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331711\" data-ts=\"1518731234\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DLR\" target=\"_blank\">DLR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331711-digital-realty-down-after-q4-ffo-miss\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Digital Realty down after Q4 FFO miss</a></h4><ul>   <li>Digital Realty Trust (NYSE:<a href='https://seekingalpha.com/symbol/DLR' title='Digital Realty Trust, Inc.'>DLR</a>) is <font color='red'>down 2.3%</font> in late trading after <a href=\"https://seekingalpha.com/news/3331651-digital-realty-trust-misses-0_04-beats-revenue\" target=\"_blank\">Q4 earnings</a> where reported and adjusted FFO measures missed slightly.</li>    <li>Adjusted FFO/share of $1.35 missed consensus for $1.39. Reported FFO/share of $1.48 was down from a year-ago $1.58; Core FFO of $1.55, however, was up from $1.43.</li>    <li>Signed bookings in Q4 are expected to generate $56M of annualized rental revenue; that brings full-year 2017 bookings to $199M.</li>    <li>Net income came to $80M, $0.26/share vs. a year-ago $0.49/share.</li>    <li>It reiterated a 2018 outlook for core FFO/share of $6.45-$6.60 and EPS of $1.50-$1.55, based on assumptions of total revenue of $3B-$3.2B; adjusted EBITDA margin of 58-60%; and G&amp;A margin of 5.5-6%. Rental rates on renewal leases or expected to be slightly negative on a cash basis, and up mid-single-digits on a GAAP basis.</li>    <li><a href=\"http://investor.digitalrealty.com/\" target=\"_blank\">Conference call</a> to come at 5:30 p.m. ET.</li>    <li><a href=\"https://seekingalpha.com/pr/17076753-digital-realty-reports-fourth-quarter-full-year-2017-results\" target=\"_blank\">Press release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3331711\" data-linked=\"Digital Realty down after Q4 FFO miss\" data-tweet=\"$DLR - Digital Realty down after Q4 FFO miss https://seekingalpha.com/news/3331711-digital-realty-down-after-q4-ffo-miss?source=tweet\" data-url=\"https://seekingalpha.com/news/3331711-digital-realty-down-after-q4-ffo-miss\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:47 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331704\" data-ts=\"1518731035\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CGNX\" target=\"_blank\">CGNX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331704-cognexminus-11_7-after-in-line-q4-eps-in-line-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cognex -11.7% after in-line Q4 EPS, in-line guidance</a></h4><ul><li>        Cognex (NASDAQ:<a href='https://seekingalpha.com/symbol/CGNX' title='Cognex Corporation'>CGNX</a>) shares are&nbsp;<font color='red'>down 11.7%</font>&nbsp;aftermarket following Q4 results that beat revenue estimates but met on EPS. In-line Q1 guidance has revenue of $165M to $175M (consensus: $173.41M).</li><li>                  More Q1 guidance: Company expects typical seasonal decline on the quarter in factory automation. Gross margin expected in the mid-70% range, within the target range under the new revenue recognition standard. Operating expenses expected up mid-single digits on the quarter. &nbsp;   </li><li>               Key metrics: Gross margin, 77% (-3 percentage points Y/Y); Research, Development &amp; Engineering expense growth, +39%; SG&amp;A expense growth, 41%; cash and equivalents, $828M.&nbsp;</li><li>               Tax impact: Company took a one-time charge of $83M due to the U.S tax reform including repatriated earnings tax, revaluation of deferred tax positions to lower rate, and the recharacterization of certain income.&nbsp;</li><li>               Earnings call is scheduled for 5 PM Eastern Time with a webcast available <a href=\"http://cgnx.client.shareholder.com/\" target=\"_blank\">here</a>.&nbsp;</li><li>               <a href=\"https://seekingalpha.com/news/3331636-cognex-eps-line-beats-revenue\" target=\"_blank\">Press release</a>&nbsp; &nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3331636-cognex-eps-line-beats-revenue\" target=\"_blank\">Cognex EPS in-line, beats on revenue</a> (Feb. 15)</li></ul><div class=\"tiny-share-widget\" data-id=\"3331704\" data-linked=\"Cognex -11.7% after in-line Q4 EPS, in-line guidance\" data-tweet=\"$CGNX - Cognex -11.7% after in-line Q4 EPS, in-line guidance https://seekingalpha.com/news/3331704-cognexminus-11_7-after-in-line-q4-eps-in-line-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3331704-cognexminus-11_7-after-in-line-q4-eps-in-line-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:43 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331666\" data-ts=\"1518729645\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ANET\" target=\"_blank\">ANET</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331666-arista-networksminus-11_4-despite-43-revenue-gain-for-q4\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Arista Networks -11.4% despite 43% revenue gain for Q4</a></h4><ul>   <li>Arista Networks (NYSE:<a href='https://seekingalpha.com/symbol/ANET' title='Arista Networks, Inc.'>ANET</a>) is <font color='red'>down 11.4%</font> in early postmarket trading despite <a href=\"https://seekingalpha.com/news/3331624-arista-beats-0_30-beats-revenue\" target=\"_blank\">Q4 results</a> that topped expectations and revenue guidance in line with Street expectations for the current quarter.</li>    <li>Revenues rose 42.7% Y/Y, and 6.9% from Q3. Gross margin rose as well, to 65.9% on a non-GAAP basis from 64.4% last year and 64.4% in the third quarter.</li>    <li>Net income rose to $103.8M from $58.8M on a GAAP basis; on a non-GAAP basis, net income rose to $137.3M from $77.5M.</li>    <li>The year marked a \"market tipping point with Arista&rsquo;s disruptive software-driven architecture gaining mainstream acceptance as we surpassed 15 million cumulative ports of cloud networking,&rdquo; says CEO Jayshree Ullal.</li>    <li>Revenue breakout: Product, $407.2M (up 41%); Service, $60.7M (up 55.7%).</li>    <li>For Q1, it's guiding to revenue of $450M-$468M (vs. consensus for $457.8M), non-GAAP gross margin of 63-65% and operating margin of about 32%.</li>    <li><a href=\"http://investors.arista.com/\" target=\"_blank\">Conference call</a> to come at 4:30 p.m. ET.</li>    <li><a href=\"https://seekingalpha.com/pr/17076694-arista-networks-inc-reports-fourth-quarter-full-year-2017-financial-results\" target=\"_blank\">Press release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3331666\" data-linked=\"Arista Networks -11.4% despite 43% revenue gain for Q4\" data-tweet=\"$ANET - Arista Networks -11.4% despite 43% revenue gain for Q4 https://seekingalpha.com/news/3331666-arista-networksminus-11_4-despite-43-revenue-gain-for-q4?source=tweet\" data-url=\"https://seekingalpha.com/news/3331666-arista-networksminus-11_4-despite-43-revenue-gain-for-q4\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:20 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>69&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331654\" data-ts=\"1518729391\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SHAK\" target=\"_blank\">SHAK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331654-shake-shack-keeps-growth-plans-on-plate\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shake Shack keeps growth plans on the plate</a></h4><ul>     <li>Shake Shack (NYSE:<a href='https://seekingalpha.com/symbol/SHAK' title='Shake Shack'>SHAK</a>) trades slightly higher after topping Q4 estimates.</li>     <li>Same-shack sales increased 0.8% during the quarter vs. -0.9% consensus. 43 Shacks were in the comparable base, compared to 29 a year ago.</li>     <li>Average weekly sales per store fell 5.6% to $85K.</li>       <li>The company reported adjusted EBITDA rose 31% Y/Y to $14.9M.</li>     <li>Shack level operating margin came in at 25.2% of sales during the quarter vs. 25.4% a year ago.</li>     <li>CEO update: \"Looking ahead, 2018 is shaping up to be another exciting year of growth with 32 to 35 new domestic company-operated Shacks, our biggest year of openings to date. We expect 16 to 18 net new licensed Shacks for the year, with a significant portion of our international growth targeted in Asia including our first Shack in Hong Kong.\"</li>     <li>Shake Shack guides for full-year revenue of $444M-$448M vs. $457.2M consensus.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3331628-shake-shack-beats-0_04-beats-revenue\" target=\"_blank\">Shake Shack beats by $0.04, beats on revenue</a> (Feb. 15)</li>     <li>SHAK<font color='green'>+0.29%</font>&nbsp;AH to $41.33.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3331654\" data-linked=\"Shake Shack keeps growth plans on the plate\" data-tweet=\"$SHAK - Shake Shack keeps growth plans on the plate https://seekingalpha.com/news/3331654-shake-shack-keeps-growth-plans-on-plate?source=tweet\" data-url=\"https://seekingalpha.com/news/3331654-shake-shack-keeps-growth-plans-on-plate\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:16 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331642\" data-ts=\"1518729128\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CBS\" target=\"_blank\">CBS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331642-cbs-beats-0_01-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CBS beats by $0.01, beats on revenue</a></h4><ul><li>CBS (NYSE:<a href='https://seekingalpha.com/symbol/CBS' title='CBS Corporation'>CBS</a>): Q4 EPS of $1.15 <font color='green'>beats by $0.01</font>.</li><li>Revenue of $3.92B (+11.4% Y/Y) <font color='green'>beats by $220M</font>.</li><li>Shares <font color='green'>+2.57%</font>.</li><li><a href=\"https://seekingalpha.com/pr/17076699-cbs-corporation-reports-2017-fourth-quarter-full-year-results\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3331642\" data-linked=\"CBS beats by $0.01, beats on revenue\" data-tweet=\"$CBS $VIAC $VIACA - CBS beats by $0.01, beats on revenue https://seekingalpha.com/news/3331642-cbs-beats-0_01-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3331642-cbs-beats-0_01-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:12 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331631\" data-ts=\"1518728920\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SNBR\" target=\"_blank\">SNBR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331631-sleep-number-beats-0_14-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sleep Number beats by $0.14, beats on revenue</a></h4><ul><li>Sleep Number (NASDAQ:<a href='https://seekingalpha.com/symbol/SNBR' title='Sleep Number Corporation'>SNBR</a>): Q4 EPS of $0.33 <font color='green'>beats by $0.14</font>.</li><li>Revenue of $363.28M (+15.9% Y/Y) <font color='green'>beats by $31.56M</font>.</li><li>Shares <font color='green'>+11.56%</font>.</li><li><a href='https://seekingalpha.com/pr/17076697-sleep-number-announces-record-fourth-quarter-full-year-2017-results'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3331631\" data-linked=\"Sleep Number beats by $0.14, beats on revenue\" data-tweet=\"$SNBR - Sleep Number beats by $0.14, beats on revenue https://seekingalpha.com/news/3331631-sleep-number-beats-0_14-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3331631-sleep-number-beats-0_14-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:08 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331628\" data-ts=\"1518728856\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SHAK\" target=\"_blank\">SHAK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331628-shake-shack-beats-0_04-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shake Shack beats by $0.04, beats on revenue</a></h4><ul><li>Shake Shack (NYSE:<a href='https://seekingalpha.com/symbol/SHAK' title='Shake Shack'>SHAK</a>): Q4 EPS of $0.10 <font color='green'>beats by $0.04</font>.</li><li>Revenue of $96.14M (+31.2% Y/Y) <font color='green'>beats by $3.27M</font>.</li><li>Shares <font color='green'>+4.54%</font>.</li><li><a href='https://seekingalpha.com/pr/17076713-shake-shack-announces-fourth-quarter-fiscal-year-ended-2017-financial-results'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3331628\" data-linked=\"Shake Shack beats by $0.04, beats on revenue\" data-tweet=\"$SHAK - Shake Shack beats by $0.04, beats on revenue https://seekingalpha.com/news/3331628-shake-shack-beats-0_04-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3331628-shake-shack-beats-0_04-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:07 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331627\" data-ts=\"1518728846\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TRUE\" target=\"_blank\">TRUE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331627-truecar-beats-0_05-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">TrueCar beats by $0.05, beats on revenue</a></h4><ul><li>TrueCar (NASDAQ:<a href='https://seekingalpha.com/symbol/TRUE' title='TrueCar, Inc'>TRUE</a>): Q4 EPS of $0.05 <font color='green'>beats by $0.05</font>.</li><li>Revenue of $83.1M (+12.2% Y/Y) <font color='green'>beats by $1.3M</font>.</li><li>Shares <font color='green'>+3%</font>.</li><li><a href='https://seekingalpha.com/pr/17076723-truecar-reports-fourth-quarter-full-year-2017-financial-results'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3331627\" data-linked=\"TrueCar beats by $0.05, beats on revenue\" data-tweet=\"$TRUE - TrueCar beats by $0.05, beats on revenue https://seekingalpha.com/news/3331627-truecar-beats-0_05-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3331627-truecar-beats-0_05-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:07 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331612\" data-ts=\"1518728369\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EQT\" target=\"_blank\">EQT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331612-eqtplus-10-following-big-q4-beat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">EQT +10% following big Q4 beat</a></h4><ul>     <li>EQT Corp. (<a href='https://seekingalpha.com/symbol/EQT' title='EQT Corporation'>EQT</a> <font color='green'>+10%</font>) cruises to a 10% gain after crushing Wall Street expectations for <a href=\"https://seekingalpha.com/news/3331316-eqt-beats-0_52-beats-revenue\" target=\"_blank\">Q4 earnings</a> and revenues on the back of higher commodity prices and sales volume.</li>     <li>EQT forecasts FY&nbsp;2018 total production sales volume of 1,520-1,560 Bcfe, with liquids volume of 12.3M-12.6M boe, while Q1 volume is seen at 350-360 Bcfe with liquids volume of 3.23M-3.25M boe.</li>     <li>The company says it spud 197 gross wells in 2017, including 144 wells drilled in the Marcellus, 49 in the Upper Devonian and four in the Utica play.</li>     <li>EQT also reports <a href=\"https://www.businesswire.com/news/home/20180215005203/en/EQT-Reports-Year-End-Proved-Reserves-21.4-TCFE\" target=\"_blank\">year-end 2017 proved reserves</a>        of 21.4T cfe, up 59% Y/Y, primarily driven by 6.3T cfe of acquisitions; excluding those, the company added 2.2T cfe of proved reserves, which was 245% more than full-year production.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3331612\" data-linked=\"EQT +10% following big Q4 beat\" data-tweet=\"$EQT - EQT +10% following big Q4 beat https://seekingalpha.com/news/3331612-eqtplus-10-following-big-q4-beat?source=tweet\" data-url=\"https://seekingalpha.com/news/3331612-eqtplus-10-following-big-q4-beat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:59 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331611\" data-ts=\"1518728174\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TKC\" target=\"_blank\">TKC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331611-turkcell-gains-revenues-ebitda-hit-records\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Turkcell gains as revenues, EBITDA hit records</a></h4><ul>   <li>Turkcell (NYSE:<a href='https://seekingalpha.com/symbol/TKC' title='Turkcell Iletisim Hizmetleri A.S.'>TKC</a>) is <font color='green'>up 2.4%</font> in the wake of <a href=\"https://seekingalpha.com/news/3331545-turkcell-iletisim-reports-q4-results\" target=\"_blank\">Q4 earnings</a> where the company hit all-time high revenues and EBITDA.</li>    <li>It also hit a nine-year high for EBITDA margin, at 37.3%, up 3.4 percentage points.</li>    <li>Revenues rose 15.4%, and EBITDA rose 26.8%.</li>    <li>Net income, meanwhile, doubled to 716M Turkish lira after excluding an impact of 500M lira from tax settlement.</li>    <li>For guidance, it's targeting group revenue growth of 13-15%, EBITDA margin of 33-35%, and operational capex-to-sales ratio of 18-19%.</li>    <li><a href=\"https://seekingalpha.com/pr/17076392-turkcell-iletisim-hizmetleri-fourth-quarter-full-year-2017-results\" target=\"_blank\">Press release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3331611\" data-linked=\"Turkcell gains as revenues, EBITDA hit records\" data-tweet=\"$TKC - Turkcell gains as revenues, EBITDA hit records https://seekingalpha.com/news/3331611-turkcell-gains-revenues-ebitda-hit-records?source=tweet\" data-url=\"https://seekingalpha.com/news/3331611-turkcell-gains-revenues-ebitda-hit-records\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:56 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331609\" data-ts=\"1518727529\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HRTX\" target=\"_blank\">HRTX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331609-heron-up-3-after-ad-com-thumbs-down-on-pacira-pharmas-exparel\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Heron up 3% after Ad Com thumbs down on Pacira Pharma&#39;s Exparel</a></h4><ul><li>Heron Therapeutics (<a href='https://seekingalpha.com/symbol/HRTX' title='Heron Therapeutics, Inc.'>HRTX</a> <font color='green'>+3.2%</font>) is up, albeit on below-average volume, after a negative FDA advisory committee vote on Pacira Pharmaceuticals' anesthetic drug EXPAREL (bupivacaine liposomal injectable solution).</li><li>Heron also has a local anesthetic candidate, HTX-011, a combination of bupivacaine and meloxicam. It plans to file a U.S. marketing application this year.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3233525-heron-therapeutics-pain-candidate-htxminus-011-shows-positive-effect-mid-stage-studies-shares\" target=\"_blank\">Heron Therapeutics' pain candidate HTX-011 shows positive effect in mid-stage studies; shares down 8% after hours on soft Sustol guidance</a> (Jan. 4, 2017)</li></ul><div class=\"tiny-share-widget\" data-id=\"3331609\" data-linked=\"Heron up 3% after Ad Com thumbs down on Pacira Pharma&#39;s Exparel\" data-tweet=\"$HRTX - Heron up 3% after Ad Com thumbs down on Pacira Pharma&#39;s Exparel https://seekingalpha.com/news/3331609-heron-up-3-after-ad-com-thumbs-down-on-pacira-pharmas-exparel?source=tweet\" data-url=\"https://seekingalpha.com/news/3331609-heron-up-3-after-ad-com-thumbs-down-on-pacira-pharmas-exparel\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:45 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331605\" data-ts=\"1518726883\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CMP\" target=\"_blank\">CMP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331605-compass-minerals-cut-to-underperform-credit-suisse-after-dim-2018-view\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Compass Minerals cut to Underperform at Credit Suisse after dim 2018 view</a></h4><ul>     <li>Compass Minerals (<a href='https://seekingalpha.com/symbol/CMP' title='Compass Minerals International, Inc.'>CMP</a> <font color='red'>-6.6%</font>) is <a href=\"https://www.benzinga.com/analyst-ratings/analyst-color/18/02/11209530/credit-suisse-gets-salty-on-compass-minerals-downgrades\" target=\"_blank\">downgraded</a> to Underperform from Neutral with a $60 price target, trimmed from $63, at Credit Suisse, after the company issued weak 2018 guidance while reporting better than expected <a href=\"https://seekingalpha.com/news/3330733-compass-minerals-beats-0_17-misses-revenue\" target=\"_blank\">Q4 earnings</a>.</li>     <li>The firm foresees multiple risks ahead for CMP including seasonal conditions in Brazil, mild winters, pressure on sulfate of potash premiums as muriate of potash prices fall, and increasing transportation costs driven by driver shortages, fuel expenses and capacity constraints.</li>     <li>CMP said it expects FY 2018 EPS of $2.75-$3.25 vs. $3.54 analyst consensus estimate, and outlook that \"places significant pressure on H2 2018 to deliver much needed growth, but we believe multiple risk factors blur earnings visibility,\" Credit Suisse writes.</li>      </ul><div class=\"tiny-share-widget\" data-id=\"3331605\" data-linked=\"Compass Minerals cut to Underperform at Credit Suisse after dim 2018 view\" data-tweet=\"$CMP - Compass Minerals cut to Underperform at Credit Suisse after dim 2018 view https://seekingalpha.com/news/3331605-compass-minerals-cut-to-underperform-credit-suisse-after-dim-2018-view?source=tweet\" data-url=\"https://seekingalpha.com/news/3331605-compass-minerals-cut-to-underperform-credit-suisse-after-dim-2018-view\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:34 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331603\" data-ts=\"1518725946\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HL\" target=\"_blank\">HL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331603-hecla-mining-posts-q4-miss-lack-of-lucky-friday-production-weighs\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hecla Mining posts Q4 miss as lack of Lucky Friday production weighs</a></h4><ul>     <li>Hecla Mining (<a href='https://seekingalpha.com/symbol/HL' title='Hecla Mining Co.'>HL</a> <font color='red'>-3.4%</font>) is lower after posting a surprise <a href=\"https://seekingalpha.com/news/3331278-hecla-mining-misses-0_11-beats-revenue\" target=\"_blank\">Q4 loss</a>, as the strike at its Lucky Friday mine holds down the company's production results.</li>     <li>HL says sales for Q4 and FY 2017 were 3% and 11% lower, respectively, than the same periods in 2016, mainly due to lower silver, zinc and lead production due to the ongoing strike at the Lucky Friday mine in Idaho.</li>     <li>Q4 silver production at Lucky Friday totaled just 69.5K oz. vs. 874K oz. in the year-ago quarter, but HL says it has agreed to binding third-party arbitration with the United Steelworkers in an attempt to end the strike, subject to a ratification vote by union members in March.</li>     <li>HL says average realized silver prices in Q4 and FY 2017 were $16.87/oz. and $17.23/oz., respectively, both slightly higher than the year-ago periods; realized prices for gold in Q4 and the full year were $1,278/oz. and $1,261/oz., respectively, 6% and 1% higher than the prior periods.</li><li>For 2018, HL projects  silver output of 9.5M-10.5 M oz., excluding any production from Lucky  Friday, and gold production of 218K-232K oz., following 2017 production of 12.5M silver oz. (down 27% from 2016) and 232.7K oz. of gold (nearly flat Y/Y).</li> </ul><div class=\"tiny-share-widget\" data-id=\"3331603\" data-linked=\"Hecla Mining posts Q4 miss as lack of Lucky Friday production weighs\" data-tweet=\"$HL - Hecla Mining posts Q4 miss as lack of Lucky Friday production weighs https://seekingalpha.com/news/3331603-hecla-mining-posts-q4-miss-lack-of-lucky-friday-production-weighs?source=tweet\" data-url=\"https://seekingalpha.com/news/3331603-hecla-mining-posts-q4-miss-lack-of-lucky-friday-production-weighs\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:19 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331599\" data-ts=\"1518724627\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HAL\" target=\"_blank\">HAL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331599-halliburton-sand-delivery-problems-may-be-widespread-analyst-says\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Halliburton sand delivery problems may be widespread, analyst says</a></h4><ul>     <li>Oilfield service companies are mostly lower after Halliburton (<a href='https://seekingalpha.com/symbol/HAL' title='Halliburton Company'>HAL</a> <font color='red'>-2.3%</font>) Executive VP and CFO Christopher Weber said the company's Q1 earnings would be <a href=\"https://seekingalpha.com/news/3331497-halliburton-warns-0_10-q1-eps-hit-sand-delivery-delays\" target=\"_blank\">reduced by $0.10/share</a> due to delays in deliveries of sand used in fracking.</li>     <li>Goldman Sachs analyst Waqar Syed thinks HAL's delivery delays likely are widespread across the industry and Q1 estimates for the entire oil service industry are at risk, although he maintains his view that fundamentals in the business are strong (source:&nbsp;Briefing.com).</li>     <li>But Tudor Pickering Holt's Byron Pope believes the delays <a href=\"https://www.reuters.com/article/us-halliburton-outlook/frack-sand-delays-to-hurt-halliburton-first-quarter-earnings-idUSKCN1FZ1ZV\" target=\"_blank\">will not affect other oilfield services companies</a>, saying \"this feels to me as though it&rsquo;s more of a Halliburton-specific issue.&rdquo;</li><li><a href='https://seekingalpha.com/symbol/SLB' title='Schlumberger Limited'>SLB</a> <font color='green'>+0.1%</font>, <a href='https://seekingalpha.com/symbol/WFT' title='Weatherford International Ltd.'>WFT</a> <font color='red'>-0.5%</font>, <a href='https://seekingalpha.com/symbol/BHGE' title='Baker Hughes, a GE company'>BHGE</a> <font color='red'>-0.8%</font>, <a href='https://seekingalpha.com/symbol/NOV' title='National Oilwell Varco, Inc.'>NOV</a> <font color='red'>-0.8%</font>, <a href='https://seekingalpha.com/symbol/WFT' title='Weatherford International Ltd.'>WFT</a> <font color='red'>-0.7%</font>, <a href='https://seekingalpha.com/symbol/NBR' title='Nabors Industries Ltd.'>NBR</a> <font color='red'>-2.4%</font>, <a href='https://seekingalpha.com/symbol/HP' title='Helmerich & Payne Inc.'>HP</a> <font color='red'>-1.2%</font>, <a href='https://seekingalpha.com/symbol/PTEN' title='Patterson-UTI Energy, Inc.'>PTEN</a> <font color='red'>-1.5%</font>, <a href='https://seekingalpha.com/symbol/RIG' title='Transocean Ltd.'>RIG</a> <font color='red'>-1.3%</font>, <a href='https://seekingalpha.com/symbol/ESV' title='Ensco PLC'>ESV</a> <font color='red'>-0.8%</font>, <a href='https://seekingalpha.com/symbol/DO' title='Diamond Offshore Drilling Inc.'>DO</a> <font color='red'>-2.5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3331599\" data-linked=\"Halliburton sand delivery problems may be widespread, analyst says\" data-tweet=\"$HAL $HAL $SLB - Halliburton sand delivery problems may be widespread, analyst says https://seekingalpha.com/news/3331599-halliburton-sand-delivery-problems-may-be-widespread-analyst-says?source=tweet\" data-url=\"https://seekingalpha.com/news/3331599-halliburton-sand-delivery-problems-may-be-widespread-analyst-says\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:57 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>33&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331598\" data-ts=\"1518724615\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SEDG\" target=\"_blank\">SEDG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331598-technology-top-gainers-losers-of-2_55-pm-2-15-18\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top Gainers / Losers as of 2.55 pm (2/15/18)</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/SEDG' title='SolarEdge Technologies'>SEDG</a> <font color='green'>+23%</font>. <a href='https://seekingalpha.com/symbol/LBCC' title='Long Blockchain Corp.'>OTCPK:LBCC</a> <font color='green'>+20%</font>. <a href='https://seekingalpha.com/symbol/SYNT' title='Syntel, Inc.'>SYNT</a> <font color='green'>+19%</font>. <a href='https://seekingalpha.com/symbol/OHGI' title='One Horizon Group, Inc.'>OHGI</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/DPW' title='DPW Holdings, Inc.'>DPW</a> <font color='green'>+10%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/INPX' title='Inpixon'>INPX</a> <font color='red'>-23%</font>. <a href='https://seekingalpha.com/symbol/LIVE' title='Live Ventures'>LIVE</a> <font color='red'>-16%</font>. <a href='https://seekingalpha.com/symbol/QUIK' title='QuickLogic Corporation'>QUIK</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/MARK' title='Remark Holdings, Inc.'>MARK</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/MATR' title='Mattersight Corporation'>MATR</a> <font color='red'>-10%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3331598\" data-linked=\"Technology - Top Gainers / Losers as of 2.55 pm (2/15/18)\" data-tweet=\"$SEDG $SEDG $LBCC - Technology - Top Gainers / Losers as of 2.55 pm (2/15/18) https://seekingalpha.com/news/3331598-technology-top-gainers-losers-of-2_55-pm-2-15-18?source=tweet\" data-url=\"https://seekingalpha.com/news/3331598-technology-top-gainers-losers-of-2_55-pm-2-15-18\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:56 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331591\" data-ts=\"1518723647\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMZN\" target=\"_blank\">AMZN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331591-yahoo-finance-amazon-plans-to-combine-amazonfresh-and-prime-now\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Yahoo Finance: Amazon plans to combine AmazonFresh and Prime Now</a></h4><ul><li>        The layoffs at Amazon (NASDAQ:<a href='https://seekingalpha.com/symbol/AMZN' title='Amazon.com, Inc.'>AMZN</a>) HQ come as the company works to consolidate its Amazon Prime Now and AmazonFresh businesses, according to <a href=\"https://finance.yahoo.com/news/exclusive-amazon-cut-hundred-jobs-144111501.html?utm_content=buffere44ca&amp;utm_medium=social&amp;utm_source=twitter.com&amp;utm_campaign=buffer\" target=\"_blank\">Yahoo Finance</a> sources.</li><li>               Prime Now offers two-hour delivery for Prime members in certain areas. AmazonFresh offers grocery delivery (in certain areas) at an additional membership fee of $14.99/month.&nbsp;</li><li>               The consolidation could streamline the delivery experience for the Whole Foods side of the business.&nbsp;</li><li>               Amazon had already begun scaling back the AmazonFresh presence shortly after the Whole Foods acquisition.&nbsp;</li><li>               Amazon shares are&nbsp;<font color='green'>up 0.88%</font>.&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3312605-recode-reports-amazon-blames-usps-fresh-failures-amazon-go-soon-public\" target=\"_blank\">Recode reports Amazon blames USPS for Fresh failures; Amazon Go soon public?</a> (Nov. 15, 2017)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3330242-seattle-times-amazon-cutting-several-hundred-hq-jobs\" target=\"_blank\">Seattle Times: Amazon cutting several hundred HQ jobs</a> (Feb. 12)</li></ul><div class=\"tiny-share-widget\" data-id=\"3331591\" data-linked=\"Yahoo Finance: Amazon plans to combine AmazonFresh and Prime Now\" data-tweet=\"$AMZN - Yahoo Finance: Amazon plans to combine AmazonFresh and Prime Now https://seekingalpha.com/news/3331591-yahoo-finance-amazon-plans-to-combine-amazonfresh-and-prime-now?source=tweet\" data-url=\"https://seekingalpha.com/news/3331591-yahoo-finance-amazon-plans-to-combine-amazonfresh-and-prime-now\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:40 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>23&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331590\" data-ts=\"1518723499\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BA\" target=\"_blank\">BA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331590-boeing-expects-to-produce-900-plus-planes-year-2020-ceo-says\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Boeing expects to produce 900-plus planes a year by 2020, CEO says</a></h4><ul>     <li>Boeing (<a href='https://seekingalpha.com/symbol/BA' title='The Boeing Company'>BA</a> <font color='green'>+3%</font>) moves out to a ~3% gain, <a href=\"https://www.marketwatch.com/story/boeings-stock-surges-adding-over-70-points-to-the-dows-price-2018-02-15\" target=\"_blank\">contributing about a third</a> of the Dow's 200-plus point gain so far today, and is now 20% higher YTD after recouping its dropoff from the recent broader stock market selloff.</li>     <li>CEO Dennis Muilenburg told CNBC today that by the end of the decade Boeing will be <a href=\"https://www.cnbc.com/2018/02/15/boeing-ceo-produce-a-plane-every-10-hours-by-2020.html\" target=\"_blank\">building more than 900 airplanes per year</a> after delivering a record 763 commercial aircraft last year.</li>     <li>\"We see air traffic growing and passenger traffic growing at about 6%-7% a year, and that's feeding airplane growth throughout the world,\" Muilenburg said, adding that the world's aircraft fleets will double in size over the next 20 years and cause a need for 41K new airplanes.</li>     <li>Separately, Reuters reports Boeing has <a href=\"https://www.reuters.com/article/us-canada-boeing-fighterjets/boeing-stays-in-race-to-supply-canada-with-fighter-jets-sources-idUSKCN1FZ2M9\" target=\"_blank\">applied to stay in the race</a> to supply Canada with 88 new fighter jets, despite angering Canada's government by launching its trade challenge against Bombardier.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3331590\" data-linked=\"Boeing expects to produce 900-plus planes a year by 2020, CEO says\" data-tweet=\"$BA - Boeing expects to produce 900-plus planes a year by 2020, CEO says https://seekingalpha.com/news/3331590-boeing-expects-to-produce-900-plus-planes-year-2020-ceo-says?source=tweet\" data-url=\"https://seekingalpha.com/news/3331590-boeing-expects-to-produce-900-plus-planes-year-2020-ceo-says\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:38 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331588\" data-ts=\"1518722897\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/YNDX\" target=\"_blank\">YNDX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331588-yandexplus-8_4-on-sherbank-e-commerce-jv\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Yandex +8.4% on Sherbank e-commerce JV</a></h4><ul><li>        Yandex (NASDAQ:<a href='https://seekingalpha.com/symbol/YNDX' title='Yandex N.V.'>YNDX</a>) and Sherbank could <a href=\"https://markets.ft.com/data/equities/tearsheet/forecasts?s=ON:NSQ\" target=\"_blank\">complete a JV</a> in March based on the former&rsquo;s e-commerce platform, according to comments from the state bank&rsquo;s CEO.</li><li>               The partnership was first revealed last summer with a binding agreement entered in December with word that the transaction would close in 1H18.&nbsp;</li><li>               Yandex shares are&nbsp;<font color='green'>up 8.4%</font>.&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3331326-yandex-misses-0_03-beats-revenue\" target=\"_blank\">Yandex misses by $0.03, beats on revenue</a> (Feb. 15)</li></ul><div class=\"tiny-share-widget\" data-id=\"3331588\" data-linked=\"Yandex +8.4% on Sherbank e-commerce JV\" data-tweet=\"$YNDX - Yandex +8.4% on Sherbank e-commerce JV https://seekingalpha.com/news/3331588-yandexplus-8_4-on-sherbank-e-commerce-jv?source=tweet\" data-url=\"https://seekingalpha.com/news/3331588-yandexplus-8_4-on-sherbank-e-commerce-jv\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:28 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331584\" data-ts=\"1518722244\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CSCO\" target=\"_blank\">CSCO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331584-cisco-hits-17-year-high-after-beat-analyst-target-hikes\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cisco hits 17-year high after beat, analyst target hikes</a></h4><ul>   <li>Cisco Systems (NASDAQ:<a href='https://seekingalpha.com/symbol/CSCO' title='Cisco Systems, Inc.'>CSCO</a>) is <font color='green'>up 4.6%</font> today and tagged its highest point in 17 years, since the dot-com bust, after a <a href=\"https://seekingalpha.com/news/3331139-cisco-plus-5_7-percent-q2-beats-upside-q3-guidance\" target=\"_blank\">stellar earnings report</a> that spurred analysts to <a href=\"https://www.benzinga.com/analyst-ratings/analyst-color/18/02/11209682/what-wall-street-is-saying-about-ciscos-q2-report\" target=\"_blank\">raise price targets</a> with eyes on the sunny outlook.</li>    <li>Cowen had expected signals that growth was ahead, and was pleased to see it's \"no longer on the horizon -- it has arrived.\" Analyst Paul Silverstein pointed to Q2 operating cash flow of $4.1B, up $300M and strongest Q2 flow in company history. He's raised his price target to $51 from $42 and sticking with an Outperform rating.</li>    <li>BofA Merrill Lynch raised its target to $53 from $46, implying 20%-plus upside. The company's transition toward software sales and recurring revenues is going well, and momentum could lead margins to expand to 64.5% within two years, says Tal Liani, projecting EPS growth of 8%, 10% and 7% for the next three years.</li>    <li>KeyBanc <a href=\"https://www.streetinsider.com/Analyst+Comments/Cisco+%28CSCO%29+PT+Raised+to+%2449+at+KeyBanc+on+2Q18+Report%3B+Broad+Demand+for+Infrastructure+Platforms...Catalyst+%26+Tax+Update+Highlight+Strong+2Q/13824530.html\" target=\"_blank\">raised its target</a> to $49 from $43, based on a positive outlook on shares amid beats driven by the recurring-revenue transition and strong order rates fueled by a Catalyst 900 refresh cycle.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3331584\" data-linked=\"Cisco hits 17-year high after beat, analyst target hikes\" data-tweet=\"$CSCO - Cisco hits 17-year high after beat, analyst target hikes https://seekingalpha.com/news/3331584-cisco-hits-17-year-high-after-beat-analyst-target-hikes?source=tweet\" data-url=\"https://seekingalpha.com/news/3331584-cisco-hits-17-year-high-after-beat-analyst-target-hikes\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:17 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331583\" data-ts=\"1518721995\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AAPL\" target=\"_blank\">AAPL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331583-apple-q4-performance-12-china-growth-51-of-global-smartphone-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Apple Q4 performance: 12% China growth, 51% of global smartphone revenue</a></h4><ul><li>        Morgan Stanley <a href=\"https://www.fastcompany.com/40531950/iphone-x-remains-strong-in-china-but-mid-range-chinese-phones-hurt-overall-iphone-sales-says-analyst?partner=feedburner&amp;utm_source=feedburner&amp;utm_medium=feed&amp;utm_campaign=Feed%3A+fastcompany%2Fheadlines+%28Fast+Company%29\" target=\"_blank\">says</a> Apple (NASDAQ:<a href='https://seekingalpha.com/symbol/AAPL' title='Apple Inc.'>AAPL</a>) iPhone shipments grew 12% in China in CY17 Q4 (Q/Q) while Android shipments declined 17%.</li><li>               In the four-week period ending January 14, the iPhone&rsquo;s market share in the region dropped to 20.6% of active phones from 21.8% in the prior four weeks.&nbsp;</li><li>               The decline hit older models like the iPhone 6 likely due to domestic phone makers slashing prices to compete. But the iPhone X continued to accelerate in the period, representing over 3% of the iPhone active installed base.</li><li>               Global Q4: Strategy Analytics has <a href=\"https://9to5mac.com/2018/02/15/apple-dominates-smartphone-marketshare-q4-2017/\" target=\"_blank\">estimates</a> for global smartphone revenue for Q4 and Apple captured 51% of wholesale revenues with an ASP of $800, which is 3x the industry average.&nbsp;</li><li>               Samsung&rsquo;s ASP grew 21% to $254 (thanks to the pricier Galaxy S8 and Galaxy Note 8).&nbsp;</li><li>               Apple shares are&nbsp;<font color='green'>up 3.1%</font>.&nbsp;&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3331583\" data-linked=\"Apple Q4 performance: 12% China growth, 51% of global smartphone revenue\" data-tweet=\"$AAPL - Apple Q4 performance: 12% China growth, 51% of global smartphone revenue https://seekingalpha.com/news/3331583-apple-q4-performance-12-china-growth-51-of-global-smartphone-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3331583-apple-q4-performance-12-china-growth-51-of-global-smartphone-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:13 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>141&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331582\" data-ts=\"1518721834\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NLY\" target=\"_blank\">NLY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331582-mortgage-reits-move-sharply-higher-earnings-roll-in\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mortgage REITs move sharply higher as earnings roll in</a></h4><ul><li>Is it possible the bad news has been priced into the mREITs? The sector is lit up bright green today following Q4 reports from Annaly (<a href='https://seekingalpha.com/symbol/NLY' title='Annaly Capital Management, Inc.'>NLY</a> <font color='green'>+2.4%</font>), Armour (<a href='https://seekingalpha.com/symbol/ARR' title='ARMOUR Residential REIT, Inc.'>ARR</a> <font color='green'>+1.4%</font>), Anworth (<a href='https://seekingalpha.com/symbol/ANH' title='Anworth Mortgage Asset Corporation'>ANH</a> <font color='green'>+2%</font>), and MFA Financial (<a href='https://seekingalpha.com/symbol/MFA' title='MFA Financial, Inc.'>MFA</a> <font color='green'>+4.1%</font>). Also reporting and also higher (after big losses early) is CYS Investments (<a href='https://seekingalpha.com/symbol/CYS' title='CYS Investments, Inc.'>CYS</a> <font color='green'>+0.8%</font>).</li><li>CYS is a particularly interesting case <a href=\"https://seekingalpha.com/news/3331174\" target=\"_blank\">as it appears to</a> hedge less than most, and thus may be the purest sector play on the yield curve. It's down a&nbsp;<font color='red'>whopping 17%</font>&nbsp;this year and trades at more than a 20% discount to Dec. 31 book value.</li><li>Other players today: AGNC Investment (<a href='https://seekingalpha.com/symbol/AGNC' title='AGNC Investment Corp.'>AGNC</a> <font color='green'>+2%</font>), Two Harbors (<a href='https://seekingalpha.com/symbol/TWO' title='Two Harbors Investment Corp.'>TWO</a> <font color='green'>+1.6%</font>), Chimera (<a href='https://seekingalpha.com/symbol/CIM' title='Chimera Investment Corporation'>CIM</a> <font color='green'>+1.9%</font>), Invesco (<a href='https://seekingalpha.com/symbol/IVR' title='Invesco Mortgage Capital Inc.'>IVR</a> <font color='green'>+2.2%</font>), Western Asset (<a href='https://seekingalpha.com/symbol/WMC' title='Western Asset Mortgage Capital Corporation'>WMC</a> <font color='green'>+1.3%</font>), AG Mortgage (<a href='https://seekingalpha.com/symbol/MITT' title='AG Mortgage Investment Trust, Inc.'>MITT</a> <font color='green'>+2.2%</font>)</li><li>ETFs: <a href='https://seekingalpha.com/symbol/MORL' title='UBS ETRACS Monthly Pay 2x Leveraged Mortgage REIT ETN'>MORL</a>, <a href='https://seekingalpha.com/symbol/REM' title='iShares Mortgage Real Estate Capped ETF'>REM</a>, <a href='https://seekingalpha.com/symbol/MORT' title='VanEck Vectors Mortgage REIT Income ETF'>MORT</a></li><li>Previously: <a href=\"https://seekingalpha.com/news/3331155-annaly-edges-higher-q4-beat\" target=\"_blank\">Annaly edges higher after Q4 beat</a> (Feb. 14)</li></ul><div class=\"tiny-share-widget\" data-id=\"3331582\" data-linked=\"Mortgage REITs move sharply higher as earnings roll in\" data-tweet=\"$NLY $NLY $ARR - Mortgage REITs move sharply higher as earnings roll in https://seekingalpha.com/news/3331582-mortgage-reits-move-sharply-higher-earnings-roll-in?source=tweet\" data-url=\"https://seekingalpha.com/news/3331582-mortgage-reits-move-sharply-higher-earnings-roll-in\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:10 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>24&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331578\" data-ts=\"1518721255\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GBR\" target=\"_blank\">GBR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331578-energy-materials-top-gainers-losers-of-2-00-pm-2-15-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy/Materials - Top Gainers / Losers as of 2:00 pm (2/15/2018)</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/GBR' title='New Concept Energy, Inc.'>GBR</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/SHLM' title='A. Schulman, Inc.'>SHLM</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/EQT' title='EQT Corporation'>EQT</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/MMLP' title='Martin Midstream Partners L.P.'>MMLP</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/NOA' title='North American Energy Partners Inc.'>NOA</a> <font color='green'>+7%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/KGC' title='Kinross Gold Corporation'>KGC</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/ROSE' title='Rosehill Resources Inc.'>ROSE</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/CCLP' title='CSI Compressco LP'>CCLP</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/PKD-OLD' title='Parker Drilling Company'>PKD-OLD</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/SND' title='Smart Sand'>SND</a> <font color='red'>-6%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3331578\" data-linked=\"Energy/Materials - Top Gainers / Losers as of 2:00 pm (2/15/2018)\" data-tweet=\"$GBR $GBR $SHLM - Energy/Materials - Top Gainers / Losers as of 2:00 pm (2/15/2018) https://seekingalpha.com/news/3331578-energy-materials-top-gainers-losers-of-2-00-pm-2-15-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3331578-energy-materials-top-gainers-losers-of-2-00-pm-2-15-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331574\" data-ts=\"1518720308\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GBTC\" target=\"_blank\">GBTC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331574-bitcoin-10k-hats-come-out-again\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bitcoin $10K hats come out again</a></h4><ul><li><font color='green'>Up another 7%&nbsp;</font>today, Bitcoin has pushed all the way to $10,150.</li><li>Has the crypto become just another risk asset? Bitcoin's bounce at the moment happens to be coinciding rather nicely with the rebound in stock prices.</li><li>The bears, meanwhile, are dragging out charts of the Nikkei circa 1989, the Nasdaq circa 2001, and the homebuilders circa 2006 to show the Bitcoin price pattern (parabolic to $20K, plunge to $6K, now retrace to $10K) fits in rather nicely with the collapse of other asset bubbles.</li><li>Related tickers: <a href='https://seekingalpha.com/symbol/GBTC' title='Grayscale Bitcoin Trust &#40;BTC&#41;'>OTCQX:GBTC</a>, <a href='https://seekingalpha.com/symbol/COIN' title='Winklevoss Bitcoin Trust ETF'>COIN</a>, <a href='https://seekingalpha.com/symbol/RIOT' title='Riot Blockchain, Inc.'>RIOT</a>, <a href='https://seekingalpha.com/symbol/OSTK' title='Overstock.com, Inc.'>OSTK</a>, <a href='https://seekingalpha.com/symbol/SSC-OLD' title='Seven Stars Cloud Group, Inc.'>SSC-OLD</a>, <a href='https://seekingalpha.com/symbol/MARA' title='Marathon Patent Group, Inc.'>MARA</a>, <a href='https://seekingalpha.com/symbol/UEPS' title='Net 1 UEPS Technologies, Inc.'>UEPS</a>, <a href='https://seekingalpha.com/symbol/BITCF' title='First Bitcoin Capital Corp.'>OTC:BITCF</a>, <a href='https://seekingalpha.com/symbol/XNET' title='Xunlei Limited'>XNET</a>, <a href='https://seekingalpha.com/symbol/GROW' title='U.S. Global Investors, Inc.'>GROW</a>, <a href='https://seekingalpha.com/symbol/BTSC' title='Bitcoin Services, Inc.'>OTCPK:BTSC</a>, <a href='https://seekingalpha.com/symbol/BTCS' title='BTCS Inc.'>OTCQB:BTCS</a>, <a href='https://seekingalpha.com/symbol/MGTI' title='MGT Capital Investments, Inc.'>OTCQB:MGTI</a>, <a href='https://seekingalpha.com/symbol/BTLLF' title='Interbit Ltd.'>OTCPK:BTLLF</a> <a href='https://seekingalpha.com/symbol/SRAX' title='Social Reality Inc.'>SRAX</a>, <a href='https://seekingalpha.com/symbol/GAHC' title='Global Arena Holding, Inc.'>OTCPK:GAHC</a>, <a href='https://seekingalpha.com/symbol/ARSC' title='American Security Resources Corp.'>OTC:ARSC</a>, <a href='https://seekingalpha.com/symbol/USTC' title='USA Real Estate Holding Co'>OTCPK:USTC</a>, <a href='https://seekingalpha.com/symbol/BLKCF' title='Global Blockchain Technologies Corp.'>OTCPK:BLKCF</a>, <a href='https://seekingalpha.com/symbol/COINB' title='Coinbase'>COINB</a>, <a href='https://seekingalpha.com/symbol/LFIN' title='LongFin Corp.A'>OTCPK:LFIN</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3331574\" data-linked=\"Bitcoin $10K hats come out again\" data-tweet=\"$GBTC $GBTC $COIN - Bitcoin $10K hats come out again https://seekingalpha.com/news/3331574-bitcoin-10k-hats-come-out-again?source=tweet\" data-url=\"https://seekingalpha.com/news/3331574-bitcoin-10k-hats-come-out-again\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:45 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>103&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331567\" data-ts=\"1518718337\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EVOK\" target=\"_blank\">EVOK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331567-evokes-planned-fda-submission-for-gimoti-extended-to-next-quarter-shares-down-11-on-women\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Evoke&#39;s planned FDA submission for Gimoti extended to next quarter; shares down 11% on women-only indication</a></h4><ul><li>Thinly traded nano cap Evoke Pharma (<a href='https://seekingalpha.com/symbol/EVOK' title='Evoke Pharma, Inc.'>EVOK</a> <font color='red'>-11.3%</font>) is down on more than triple normal volume, albeit on turnover of only 266K shares, in response to its <a href=\"https://seekingalpha.com/pr/17075731-evoke-announces-discovery-sex-based-pharmacokinetic-differences-gimoti\" target=\"_blank\">announcement </a>that it expects to file its U.S. marketing application next quarter for Gimoti (metoclopramide) for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women.</li><li>The company also announced that further analyses of pharmacokinetic data showed significant differences in metoclopramide exposure between men and women, much lower in men, prompting their exclusion from its marketing application. The company's decision to seek approval for women only will restrict the targeted treatment population since men represent ~20% of diabetic gastroparesis cases.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3302895-evoke-submit-u-s-marketing-application-gimoti-q1-shares-ahead-14-percent-preamarket\" target=\"_blank\">Evoke to submit U.S. marketing application for Gimoti in Q1; shares ahead 14% preamarket</a> (Oct. 23, 2017)</li></ul><div class=\"tiny-share-widget\" data-id=\"3331567\" data-linked=\"Evoke&#39;s planned FDA submission for Gimoti extended to next quarter; shares down 11% on women-only indication\" data-tweet=\"$EVOK - Evoke&#39;s planned FDA submission for Gimoti extended to next quarter; shares down 11% on women-only indication https://seekingalpha.com/news/3331567-evokes-planned-fda-submission-for-gimoti-extended-to-next-quarter-shares-down-11-on-women?source=tweet\" data-url=\"https://seekingalpha.com/news/3331567-evokes-planned-fda-submission-for-gimoti-extended-to-next-quarter-shares-down-11-on-women\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:12 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331571\" data-ts=\"1518717633\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ARES\" target=\"_blank\">ARES</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331571-financials-top-5-gainers-losers-of-1-00-pm-02-15-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financials - Top 5 Gainers / Losers as of 1:00 PM (02/15/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/ARES' title='Ares Management Corporation'>ARES</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/NTB' title='The Bank of N.T. Butterfield & Son'>NTB</a> <font color='green'>+10%</font>.<a href='https://seekingalpha.com/symbol/SBCF' title='Seacoast Banking Corporation of Florida'>SBCF</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/JP' title='Jupai Holdings'>JP</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/UFCS' title='United Fire Group'>UFCS</a> <font color='green'>+7%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/FPAY' title='FlexShopper, Inc.'>FPAY</a> <font color='red'>-20%</font>. <a href='https://seekingalpha.com/symbol/NHLD' title='National Holdings Corp.'>NHLD</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/TRUP' title='Trupanion'>TRUP</a> <font color='red'>-5%</font>. <a href='https://seekingalpha.com/symbol/FRSX' title='Foresight Autonomous Holdings Ltd.'>FRSX</a> <font color='red'>-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3331571\" data-linked=\"Financials - Top 5 Gainers / Losers as of 1:00 PM (02/15/2018)\" data-tweet=\"$ARES $ARES $NTB - Financials - Top 5 Gainers / Losers as of 1:00 PM (02/15/2018) https://seekingalpha.com/news/3331571-financials-top-5-gainers-losers-of-1-00-pm-02-15-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3331571-financials-top-5-gainers-losers-of-1-00-pm-02-15-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331568\" data-ts=\"1518717402\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ABBV\" target=\"_blank\">ABBV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331568-abbvie-bumps-dividend-35-to-buy-back-10b-of-stock\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AbbVie bumps dividend 35%, to buy back $10B of stock</a></h4><ul><li>AbbVie (<a href='https://seekingalpha.com/symbol/ABBV' title='AbbVie Inc.'>ABBV</a> <font color='green'>+1%</font>) <a href=\"https://seekingalpha.com/pr/17076485-abbvie-increases-dividend-announces-new-stock-repurchase-program\" target=\"_blank\">announces </a>a 35% increase in its quarterly cash dividend to $0.96 per share. In addition, the board has authorized a new $10B stock repurchase program.</li></ul><div class=\"tiny-share-widget\" data-id=\"3331568\" data-linked=\"AbbVie bumps dividend 35%, to buy back $10B of stock\" data-tweet=\"$ABBV - AbbVie bumps dividend 35%, to buy back $10B of stock https://seekingalpha.com/news/3331568-abbvie-bumps-dividend-35-to-buy-back-10b-of-stock?source=tweet\" data-url=\"https://seekingalpha.com/news/3331568-abbvie-bumps-dividend-35-to-buy-back-10b-of-stock\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:56 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>59&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331564\" data-ts=\"1518716953\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/UUUU\" target=\"_blank\">UUUU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331564-energy-fuels-names-chalmers-president-ceo-frydenlund-cfo\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy Fuels names Chalmers as President/CEO, Frydenlund as CFO</a></h4><ul>     <li>Energy Fuels (<a href='https://seekingalpha.com/symbol/UUUU' title='Energy Fuels Inc'>UUUU</a> <font color='red'>-2.6%</font>) announces <a href=\"https://seekingalpha.com/pr/17075403-energy-fuels-announces-management-streamlining\" target=\"_blank\">changes in top management</a>, appointing Mark Chalmers as its new President and CEO, General Counsel David Frydenlund as CFO, and Eexcutive VP Paul Goranson as COO.</li>     <li>Chalmers joined UUUU in July 2016 after serving as executive GM of production for Paladin Energy, where he oversaw operations of the Langer Heinrich and Kayelekera mines in Africa.</li>     <li>Frydenlund will replace current CFO Daniel Zang, who will leave the company on March 1; UUUU says Frydenlund has worked in the U.S. uranium mining industry since 1997.</li></ul><div class=\"tiny-share-widget\" data-id=\"3331564\" data-linked=\"Energy Fuels names Chalmers as President/CEO, Frydenlund as CFO\" data-tweet=\"$UUUU - Energy Fuels names Chalmers as President/CEO, Frydenlund as CFO https://seekingalpha.com/news/3331564-energy-fuels-names-chalmers-president-ceo-frydenlund-cfo?source=tweet\" data-url=\"https://seekingalpha.com/news/3331564-energy-fuels-names-chalmers-president-ceo-frydenlund-cfo\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:49 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331561\" data-ts=\"1518716696\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ABBV\" target=\"_blank\">ABBV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331561-abbvie-shares-halted-pending-news\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AbbVie shares halted pending news</a></h4><ul><li>Nasdaq has suspended trading in AbbVie (<a href='https://seekingalpha.com/symbol/ABBV' title='AbbVie Inc.'>ABBV</a> <font color='green'>+1%</font>) pending the release of news.</li></ul><div class=\"tiny-share-widget\" data-id=\"3331561\" data-linked=\"AbbVie shares halted pending news\" data-tweet=\"$ABBV - AbbVie shares halted pending news https://seekingalpha.com/news/3331561-abbvie-shares-halted-pending-news?source=tweet\" data-url=\"https://seekingalpha.com/news/3331561-abbvie-shares-halted-pending-news\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:44 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>49&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331559\" data-ts=\"1518716415\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MBRX\" target=\"_blank\">MBRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331559-midday-gainers-losers-2-15-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers (2/15/2018)</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/MBRX' title='Moleculin Biotech, Inc.'>MBRX</a> <font color='green'>+61%</font>. <a href='https://seekingalpha.com/symbol/AMAG' title='AMAG Pharmaceuticals, Inc.'>AMAG</a> <font color='green'>+29%</font>. <a href='https://seekingalpha.com/symbol/GLMD' title='Galmed Pharmaceuticals Ltd.'>GLMD</a> <font color='green'>+24%</font>. <a href='https://seekingalpha.com/symbol/SEDG' title='SolarEdge Technologies'>SEDG</a> <font color='green'>+20%</font>. <a href='https://seekingalpha.com/symbol/LBCC' title='Long Blockchain Corp.'>OTCPK:LBCC</a> <font color='green'>+21%</font>. <a href='https://seekingalpha.com/symbol/BBW' title='Build-A-Bear Workshop, Inc.'>BBW</a> <font color='green'>+17%</font>. COOL <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/ANDE' title='The Andersons, Inc.'>ANDE</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/WBAI' title='500.com Limited'>WBAI</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/ATRS' title='Antares Pharma Inc.'>ATRS</a> <font color='green'>+15%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/INPX' title='Inpixon'>INPX</a> <font color='red'>-25%</font>. <a href='https://seekingalpha.com/symbol/FPAY' title='FlexShopper, Inc.'>FPAY</a> <font color='red'>-20%</font>. <a href='https://seekingalpha.com/symbol/CAI' title='CAI International, Inc.'>CAI</a> <font color='red'>-19%</font>. <a href='https://seekingalpha.com/symbol/TGH' title='Textainer Group Holdings Limited'>TGH</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/DMPI' title='DelMar Pharmaceuticals, Inc.'>DMPI</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/NHLD' title='National Holdings Corp.'>NHLD</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/THS' title='TreeHouse Foods, Inc.'>THS</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/LIVE' title='Live Ventures'>LIVE</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/ADMP' title='Adamis Pharmaceuticals Corp.'>ADMP</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/ARDM' title='Aradigm Corp.'>OTC:ARDM</a> <font color='red'>-13%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3331559\" data-linked=\"Midday Gainers / Losers (2/15/2018)\" data-tweet=\"$MBRX $MBRX $AMAG - Midday Gainers / Losers (2/15/2018) https://seekingalpha.com/news/3331559-midday-gainers-losers-2-15-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3331559-midday-gainers-losers-2-15-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:40 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331556\" data-ts=\"1518716214\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KURA\" target=\"_blank\">KURA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331556-kura-oncology-up-1-on-mid-stage-tipifarnib-data-in-hnscc\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Kura Oncology up 1% on mid-stage tipifarnib data in HNSCC</a></h4><ul><li>Kura Oncology (<a href='https://seekingalpha.com/symbol/KURA' title='Kura Oncology'>KURA</a> <font color='green'>+1.3%</font>) is up on lower-than-average volume on the heels of its <a href=\"https://seekingalpha.com/pr/17076329-kura-oncology-provides-update-phase-2-trial-tipifarnib-hras-mutant-head-neck-cancer\" target=\"_blank\">announcement </a>of updated results from a <a href=\"https://clinicaltrials.gov/ct2/show/NCT02383927?intr=tipifarnib&amp;spons=kura+oncology&amp;phase=1&amp;rank=3\" target=\"_blank\">Phase 2 clinical trial</a> assessing tipifarnib in patients with head and neck squamous cell carcinomas &#40;HNSCC&#41; with HRAS mutations. The data are being presented today at the Multidisciplinary Head and Neck Cancers Symposium in Scottsdale, AZ.</li><li>Nine HRAS mutation-positive HNSCC patients have been enrolled to date. 83% (n=5/6) of evaluable patients have experienced partial responses. The other one experienced tumor shrinkage and prolonged cancer stabilization. Two have shown durable responses of more than 18 months.</li><li>Recruitment is ongoing. Target enrollment is 36.</li><li><a href=\"http://www.kuraoncology.com/pipeline/tipifarnib-hras/\" target=\"_blank\">Tipifarnib&nbsp;</a>inhibits an enzyme called farnesyl transferase. Interfering with its function inhibits protein farnesylation, a key signaling process in cancer initiation and development. Farnesyl transferase inhibitors have shown particular promise in blocking HRAS (an oncogene) farnesylation.</li></ul><div class=\"tiny-share-widget\" data-id=\"3331556\" data-linked=\"Kura Oncology up 1% on mid-stage tipifarnib data in HNSCC\" data-tweet=\"$KURA - Kura Oncology up 1% on mid-stage tipifarnib data in HNSCC https://seekingalpha.com/news/3331556-kura-oncology-up-1-on-mid-stage-tipifarnib-data-in-hnscc?source=tweet\" data-url=\"https://seekingalpha.com/news/3331556-kura-oncology-up-1-on-mid-stage-tipifarnib-data-in-hnscc\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:36 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331554\" data-ts=\"1518715748\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CBB\" target=\"_blank\">CBB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331554-cincinnati-bellminus-3_6-revenue-guidance-come-up-short\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cincinnati Bell -3.6% as revenue, guidance come up short</a></h4><ul>   <li>Cincinnati Bell (NYSE:<a href='https://seekingalpha.com/symbol/CBB' title='Cincinnati Bell Inc.'>CBB</a>) is <font color='red'>off 3.6%</font> after missing on top and bottom lines in its <a href=\"https://seekingalpha.com/news/3331372-cincinnati-bell-misses-0_24-misses-revenue\" target=\"_blank\">Q4 earnings report</a> and providing guidance short of expectations for the full year.</li>    <li>Revenues got a boost from its OnX acquisition but fell short of consensus. Strategic revenues rose 21% to $201M, the company noted, with Fioptics revenue up 17%.</li>    <li>Operating income fell to $10M from a prior-year $11M; Net loss was $16M.</li>    <li>EBITDA of $78.4M missed an expected $81M.</li>    <li>Revenue by segment: Entertainment and Communications, $197M (up 2%); IT Services and Hardware, $233M (up $138M after $150M contribution from OnX acquisition).</li>    <li>For 2018, it's guiding to revenues of $1.2B-$1.275B (below consensus for $1.646B) and EBITDA of $320M-$330M (light of consensus for $331.8M).</li>    <li><a href=\"https://seekingalpha.com/pr/17075706-cincinnati-bell-reports-fourth-quarter-full-year-2017-results\" target=\"_blank\">Press release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3331554\" data-linked=\"Cincinnati Bell -3.6% as revenue, guidance come up short\" data-tweet=\"$CBB - Cincinnati Bell -3.6% as revenue, guidance come up short https://seekingalpha.com/news/3331554-cincinnati-bellminus-3_6-revenue-guidance-come-up-short?source=tweet\" data-url=\"https://seekingalpha.com/news/3331554-cincinnati-bellminus-3_6-revenue-guidance-come-up-short\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:29 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331546\" data-ts=\"1518714504\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OMC\" target=\"_blank\">OMC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331546-omnicom-down-6-western-markets-drag-revenue-growth\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Omnicom down 6% as western markets drag revenue growth</a></h4><ul>   <li>Ad giant Omnicom (NYSE:<a href='https://seekingalpha.com/symbol/OMC' title='Omnicom Group Inc.'>OMC</a>) has <font color='red'>slipped 6%</font> after <a href=\"https://seekingalpha.com/news/3331328-omnicom-beats-0_01-misses-revenue\" target=\"_blank\">Q4 revenues</a> fell just short of expectations in a hotly competitive sector.</li>    <li>Net income fell 27% to $254.4M; the company logged a net increase of $106.3M in income tax expense due to the passage of federal tax reform legislation. Excluding that, net income ticked up 3% to $360.7M.</li>    <li>Revenue, though, dipped 1.5%. Organic growth by region: Euro Markets and other Europe up 8.2%; Asia Pacific up 6%; Middle East/Africa up 1.9%; North America -0.8%; UK -0.7%; Latin America -0.3%.</li>    <li>Operating profit rose 3% to $620.1M.</li>    <li>Organic growth by discipline: Advertising, up 1.2%; CRM Consumer Experience, up 3.4%; CRM Execution and Support, up 3.4%; Public Relations up 0.1%; Healthcare down 1.9%.</li>    <li><a href=\"https://seekingalpha.com/pr/17075610-omnicom-group-reports-fourth-quarter-full-year-2017-results\" target=\"_blank\">Press release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3331546\" data-linked=\"Omnicom down 6% as western markets drag revenue growth\" data-tweet=\"$OMC - Omnicom down 6% as western markets drag revenue growth https://seekingalpha.com/news/3331546-omnicom-down-6-western-markets-drag-revenue-growth?source=tweet\" data-url=\"https://seekingalpha.com/news/3331546-omnicom-down-6-western-markets-drag-revenue-growth\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:08 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331541\" data-ts=\"1518714332\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PFSCF\" target=\"_blank\">PFSCF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331541-prometics-iaip-orphan-drug-in-u-s-for-preemie-inflammatory-bowel-disorder-shares-up-2\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Prometic&#39;s IaIP an Orphan Drug in U.S. for preemie inflammatory bowel disorder; shares up 2%</a></h4><ul><li>Thinly traded Prometic Life Sciences (<a href='https://seekingalpha.com/symbol/PFSCF' title='ProMetic Life Sciences Inc.'>OTCQX:PFSCF</a> <font color='green'>+1.6%</font>) is up on light volume on the heels of its <a href=\"https://seekingalpha.com/pr/17075961-prometic-granted-orphan-drug-designation-fda-inter-alpha-inhibitor-proteins-treatment\" target=\"_blank\">announcement </a>that the FDA has designated its Inter-Alpha-Inhibitor-Proteins (IaIP) an Orphan Drug for the treatment of <a href=\"https://www.chla.org/necrotizing-enterocolitis\" target=\"_blank\">necrotizing enterocolitis</a>, a bacterial infection in the intestinal wall that strikes ~10% of premature infants.</li><li>IaIP are naturally occurring proteins that control excessive inflammatory responses to toxins, infectious agents and tissue/organ damage.</li><li>Among the benefits of Orphan Drug status in the U.S. is a seven-year period of market exclusivity for the indication, if approved.</li></ul><div class=\"tiny-share-widget\" data-id=\"3331541\" data-linked=\"Prometic&#39;s IaIP an Orphan Drug in U.S. for preemie inflammatory bowel disorder; shares up 2%\" data-tweet=\"$PFSCF - Prometic&#39;s IaIP an Orphan Drug in U.S. for preemie inflammatory bowel disorder; shares up 2% https://seekingalpha.com/news/3331541-prometics-iaip-orphan-drug-in-u-s-for-preemie-inflammatory-bowel-disorder-shares-up-2?source=tweet\" data-url=\"https://seekingalpha.com/news/3331541-prometics-iaip-orphan-drug-in-u-s-for-preemie-inflammatory-bowel-disorder-shares-up-2\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:05 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331543\" data-ts=\"1518714080\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ANDE\" target=\"_blank\">ANDE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331543-consumer-top-gainers-losers-of-12-00-pm-2-15-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer - Top Gainers / Losers as of 12:00 pm (2/15/2018)</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/ANDE' title='The Andersons, Inc.'>ANDE</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/AVP' title='Avon Products, Inc.'>AVP</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/LTRPA' title='Liberty TripAdvisor Holdings A'>LTRPA</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/POOL' title='Pool Corporation'>POOL</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/VNCE' title='Vince Holding Corp.'>VNCE</a> <font color='green'>+6%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/THS' title='TreeHouse Foods, Inc.'>THS</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/FORD' title='Forward Industries, Inc.'>FORD</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/FOSL' title='Fossil, Inc.'>FOSL</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/ICON' title='Iconix Brand Group, Inc.'>ICON</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/ABAC-OLD' title='Renmin Tianli Group'>ABAC-OLD</a> <font color='red'>-8%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3331543\" data-linked=\"Consumer - Top Gainers / Losers as of 12:00 pm (2/15/2018)\" data-tweet=\"$ANDE $ANDE $AVP - Consumer - Top Gainers / Losers as of 12:00 pm (2/15/2018) https://seekingalpha.com/news/3331543-consumer-top-gainers-losers-of-12-00-pm-2-15-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3331543-consumer-top-gainers-losers-of-12-00-pm-2-15-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:01 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331539\" data-ts=\"1518713607\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SYNT\" target=\"_blank\">SYNT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331539-syntelplus-13_7-on-q4-beats-upside-rev-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Syntel +13.7% on Q4 beats, upside rev. guidance</a></h4><ul><li>        Syntel (NASDAQ:<a href='https://seekingalpha.com/symbol/SYNT' title='Syntel, Inc.'>SYNT</a>) shares are&nbsp;<font color='green'>up 13.7%</font>&nbsp;following yesterday&rsquo;s Q4 report that beat revenue and EPS estimates.</li><li>               FY18 guidance: Revenue, $905M to $950M (consensus: $892.14M); EPS, $1.72 to $1.92 (consensus: $1.80).&nbsp;</li><li>               <a href=\"https://seekingalpha.com/pr/17075932-syntel-reports-fourth-quarter-full-year-2017-financial-results\" target=\"_blank\">Press release</a>&nbsp; &nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3331432-syntel-beats-0_23-beats-revenue\" target=\"_blank\">Syntel beats by $0.23, beats on revenue</a> (Feb. 15)</li></ul><div class=\"tiny-share-widget\" data-id=\"3331539\" data-linked=\"Syntel +13.7% on Q4 beats, upside rev. guidance\" data-tweet=\"$SYNT - Syntel +13.7% on Q4 beats, upside rev. guidance https://seekingalpha.com/news/3331539-syntelplus-13_7-on-q4-beats-upside-rev-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3331539-syntelplus-13_7-on-q4-beats-upside-rev-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:53 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331536\" data-ts=\"1518713125\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TNDM\" target=\"_blank\">TNDM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331536-tandems-insulin-pump-glucose-suspend-feature-showed-benefit-in-home-study-investors-unmoved\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tandem&#39;s insulin pump with glucose suspend feature showed benefit in at-home study; investors unmoved, shared down 4%</a></h4><ul><li>Tandem Diabetes Care (<a href='https://seekingalpha.com/symbol/TNDM' title='Tandem Diabetes Care, Inc.'>TNDM</a> <font color='red'>-4.4%</font>) slips on average volume as investors appear unimpressed with the <a href=\"https://seekingalpha.com/pr/17076164-reduced-time-hypoglycemia-demonstrated-tandem-diabetes-care-s-pivotal-trial-t-slim-x2-insulin\" target=\"_blank\">results </a>from a study evaluating the effect of a predictive low glucose suspend feature in its t:slim X2 Insulin Pump. The results are being presented today at the Annual Conference on Advanced Technologies and Treatments for Diabetes &#40;ATTD&#41; in Vienna, Austria.</li><li>The study, called PROLOG, compared t:slim X2 with Basal-IQ (the glucose suspend feature) to its standard t:slim X2 Pump in type 1 diabetics over two three-week periods of at-home insulin pump use, one period with each pump.</li><li>Patients using the pump with Basal-IQ experienced a 31% reduction in the number of sensor glucose readings below 70 mg/dL (threshold for hypoglycemia) compared to the standard pump. The positive impact on hypoglycemia was achieved with no increase in the rate of high glucose (hyperglycemia).</li><li>CEO Kim Blickenstaff says, &ldquo;Reducing the risk of hypoglycemia has been the most requested feature of automated insulin delivery in our market research, due to the severity of the complications when left untreated. The data from this study supports our mission to improve the lives of people with diabetes through new innovations, such as the t:slim X2 Pump with Basal-IQ technology. These results will support a PMA submission that we are on track to submit this quarter, and we continue to prepare for a launch in summer of 2018, pending FDA review and approval.&rdquo;</li></ul><div class=\"tiny-share-widget\" data-id=\"3331536\" data-linked=\"Tandem&#39;s insulin pump with glucose suspend feature showed benefit in at-home study; investors unmoved, shared down 4%\" data-tweet=\"$TNDM - Tandem&#39;s insulin pump with glucose suspend feature showed benefit in at-home study; investors unmoved, shared down 4% https://seekingalpha.com/news/3331536-tandems-insulin-pump-glucose-suspend-feature-showed-benefit-in-home-study-investors-unmoved?source=tweet\" data-url=\"https://seekingalpha.com/news/3331536-tandems-insulin-pump-glucose-suspend-feature-showed-benefit-in-home-study-investors-unmoved\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:45 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331535\" data-ts=\"1518712945\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MXIM\" target=\"_blank\">MXIM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331535-nar-maxim-still-on-renesas-acquisition-shortlist\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">NAR: Maxim still on Renesas acquisition shortlist</a></h4><ul><li>        Maxim Integrated Products (NASDAQ:<a href='https://seekingalpha.com/symbol/MXIM' title='Maxim Integrated Products, Inc.'>MXIM</a>) shares move&nbsp;<font color='green'>up 2.2%</font>&nbsp;on a <a href=\"https://asia.nikkei.com/Business/Companies/Leaner-Renesas-seeks-to-gain-muscle-via-M-As?page=1\" target=\"_blank\">Nikkei Asian Review</a> report that the company remains on &ldquo;a shortlist of potential buyout targets&rdquo; for chipmaker Renesas (<a href='https://seekingalpha.com/symbol/RNECY' title='Renesas Electronics Corp ADR'>OTCPK:RNECY</a>).</li><li>               Last month, Maxim shares spiked after CNBC reported talks for a potential $20B acquisition.&nbsp;</li><li>               Renesas dismissed the reports at the time.&nbsp;</li><li>               NAR says Maxim remains on the list but that the plan &ldquo;entails some risks&rdquo; as too high a price would force Renesas to book a \"considerable amount\" of goodwill that could dent operating profit.&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3326158-maxim-integrated-plus-12_3-percent-acquisition-target-news\" target=\"_blank\">Maxim Integrated +12.3% on acquisition target news</a> (Jan. 29)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3326267-renesas-dismisses-report-talks-buy-maxim\" target=\"_blank\">Renesas dismisses report on talks to buy Maxim</a> (Jan. 30)</li></ul><div class=\"tiny-share-widget\" data-id=\"3331535\" data-linked=\"NAR: Maxim still on Renesas acquisition shortlist\" data-tweet=\"$MXIM $MXIM $RNECY - NAR: Maxim still on Renesas acquisition shortlist https://seekingalpha.com/news/3331535-nar-maxim-still-on-renesas-acquisition-shortlist?source=tweet\" data-url=\"https://seekingalpha.com/news/3331535-nar-maxim-still-on-renesas-acquisition-shortlist\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:42 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331529\" data-ts=\"1518711929\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RS\" target=\"_blank\">RS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331529-reliance-steel-hits-52-week-high-after-q4-beat-above-consensus-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Reliance Steel hits 52-week high after Q4 beat, above-consensus guidance</a></h4><ul>     <li>Reliance Steel (<a href='https://seekingalpha.com/symbol/RS' title='Reliance Steel & Aluminum Co.'>RS</a> <font color='green'>+2.7%</font>) surges to 52-week highs after reporting a strong <a href=\"https://seekingalpha.com/news/3331338-reliance-steel-and-aluminum-beats-0_22-beats-revenue\" target=\"_blank\">Q4 earnings</a> beat and guiding Q1 earnings above consensus.</li>     <li>RS says Q4 revenues rose 15% Y/Y to $2.38B and tons sold during quarter increased 6.3% Y/Y but fell 4.6% Q/Q, with the average selling price per ton sold 8.8% higher than the year-ago quarter and 1.8% above Q3 levels.</li>     <li>Q4 gross profit margin was 28.6% vs. 29.8% a year ago and 28% in Q3 2017.</li>     <li>RS issues upside guidance for Q1, seeing EPS of $1.90-$2.00 vs. $1.80 analyst consensus estimate, and the company estimates tons sold will increase 6%-8% Q/Q with average selling prices rising 4%-6%.</li>     <li>RS also raises its quarterly dividend by 11.1% to $0.50/share.</li></ul><div class=\"tiny-share-widget\" data-id=\"3331529\" data-linked=\"Reliance Steel hits 52-week high after Q4 beat, above-consensus guidance\" data-tweet=\"$RS - Reliance Steel hits 52-week high after Q4 beat, above-consensus guidance https://seekingalpha.com/news/3331529-reliance-steel-hits-52-week-high-after-q4-beat-above-consensus-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3331529-reliance-steel-hits-52-week-high-after-q4-beat-above-consensus-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:25 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331527\" data-ts=\"1518711664\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CELG\" target=\"_blank\">CELG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331527-celgenes-otezla-shows-positive-effect-in-mid-stage-uc-study-shares-up-2\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Celgene&#39;s Otezla shows positive effect in mid-stage UC study; shares up 2%</a></h4><ul><li>Celgene (<a href='https://seekingalpha.com/symbol/CELG' title='Celgene Corporation'>CELG</a> <font color='green'>+2.2%</font>) is up on below-average volume in response to its <a href=\"https://seekingalpha.com/pr/17076181-otezla-apremilast-phase-ii-data-showed-clinically-meaningful-improvements-patients-active\" target=\"_blank\">announcement </a>of positive results from a <a href=\"https://clinicaltrials.gov/ct2/show/NCT02289417?cond=Ulcerative+Colitis&amp;intr=apremilast&amp;spons=celgene&amp;phase=1&amp;rank=1\" target=\"_blank\">Phase 2 clinical trial</a> evaluating OTEZLA (apremilast) in patients with active ulcerative colitis &#40;UC&#41; who had failed at least one prior line of treatment but no biologic therapy. The data were presented at ECCO in Vienna, Austria.</li><li>The primary endpoint was the proportion of subjects achieving clinical remission at week 12 as measured by Total Mayo Score &#40;TMS&#41;. 21.8% (n=12/55) of patients receiving 40 mg of OTEZLA twice daily achieved clinical remission compared to 13.8% (n=8/58) for placebo (p=non-significant).</li><li>In the 30 mg apremilast arm, 31.6% (n=18/57) of patients achieved clinical remission versus placebo's 13.8% (p&lt;0.05).</li><li>The FDA has designated apremilast an Orphan Drug for pediatric UC. <a href=\"https://www.otezla.com/\" target=\"_blank\">OTEZLA </a>was approved in the U.S. in 2014 for plaque psoriasis and psoriatic arthritis.</li></ul><div class=\"tiny-share-widget\" data-id=\"3331527\" data-linked=\"Celgene&#39;s Otezla shows positive effect in mid-stage UC study; shares up 2%\" data-tweet=\"$CELG - Celgene&#39;s Otezla shows positive effect in mid-stage UC study; shares up 2% https://seekingalpha.com/news/3331527-celgenes-otezla-shows-positive-effect-in-mid-stage-uc-study-shares-up-2?source=tweet\" data-url=\"https://seekingalpha.com/news/3331527-celgenes-otezla-shows-positive-effect-in-mid-stage-uc-study-shares-up-2\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:21 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331485\" data-ts=\"1518710833\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MBRX\" target=\"_blank\">MBRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331485-healthcare-top-5-gainers-losers-of-11-00-2-15-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare - Top 5 Gainers / Losers as of 11:00 am (2/15/2018)</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/MBRX' title='Moleculin Biotech, Inc.'>MBRX</a> <font color='green'>+55%</font>. <a href='https://seekingalpha.com/symbol/AMAG' title='AMAG Pharmaceuticals, Inc.'>AMAG</a> <font color='green'>+27%</font>. <a href='https://seekingalpha.com/symbol/GLMD' title='Galmed Pharmaceuticals Ltd.'>GLMD</a> <font color='green'>+21%</font>. COOL <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/DNLI' title='Denali Therapeutics, Inc.'>DNLI</a> <font color='green'>+12%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/DMPI' title='DelMar Pharmaceuticals, Inc.'>DMPI</a> <font color='red'>-21%</font>. <a href='https://seekingalpha.com/symbol/ADMP' title='Adamis Pharmaceuticals Corp.'>ADMP</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/TYHT' title='Shineco, Inc.'>TYHT</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/BSPM' title='Biostar Pharmaceutic'>OTC:BSPM</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/AEMD' title='Aethlon Medical, Inc.'>AEMD</a> <font color='red'>-10%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3331485\" data-linked=\"Healthcare - Top 5 Gainers / Losers as of 11:00 am (2/15/2018)\" data-tweet=\"$MBRX $MBRX $AMAG - Healthcare - Top 5 Gainers / Losers as of 11:00 am (2/15/2018) https://seekingalpha.com/news/3331485-healthcare-top-5-gainers-losers-of-11-00-2-15-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3331485-healthcare-top-5-gainers-losers-of-11-00-2-15-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:07 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331512\" data-ts=\"1518710263\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PTE\" target=\"_blank\">PTE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331512-buying-ramps-up-in-polarityte-shares-ahead-18\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Buying ramps up in PolarityTE, shares ahead 18%</a></h4><ul><li>Thinly traded micro cap PolarityTE (COOL <font color='green'>+18.3%</font>) is up on more than double normal volume, albeit on turnover of less than 260K shares. Buying perked up after Cantor Fitzgerald issued a bullish note (OVERWEIGHT/$70) on the regenerative medicine outfit.</li><li>Cantor says the company's recently launched <a href=\"https://www.polarityte.com/products/skinte\" target=\"_blank\">SkinTE</a> should be a winner since a dime-sized biopsy can yield enough skin tissue to cover an entire arm. A recent case involved a young boy with a badly scarred chest from a burn who received SkinTE. In about a month, the area had full pigmentation, minimal scarring and minimal contracture.</li></ul><div class=\"tiny-share-widget\" data-id=\"3331512\" data-linked=\"Buying ramps up in PolarityTE, shares ahead 18%\" data-tweet=\"$PTE - Buying ramps up in PolarityTE, shares ahead 18% https://seekingalpha.com/news/3331512-buying-ramps-up-in-polarityte-shares-ahead-18?source=tweet\" data-url=\"https://seekingalpha.com/news/3331512-buying-ramps-up-in-polarityte-shares-ahead-18\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:57 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331510\" data-ts=\"1518709718\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMAT\" target=\"_blank\">AMAT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331510-stifel-raises-applied-materials-target-to-37-upside\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Stifel raises Applied Materials target to 37% upside</a></h4><ul><li>        Stifel <a href=\"https://www.benzinga.com/analyst-ratings/analyst-color/18/02/11209213/stifel-applied-materials-beat-and-raise-q1-dividend-boo\" target=\"_blank\">maintains</a> a Buy rating and raises its Applied Materials (NASDAQ:<a href='https://seekingalpha.com/symbol/AMAT' title='Applied Materials, Inc.'>AMAT</a>) price target from $66 to $71, a 37% upside to yesterday&rsquo;s close.</li><li>               Analyst Patrick Ho cites positive FY18 outlook, which should lead to overperformance compared to its peers,&nbsp; and management tracking ahead of 2020 operating model targets.&nbsp;</li><li>               Ho says the company will continue to generate a &ldquo;significant amount of cash&rdquo; and won&rsquo;t need to hoard cash when a market downturn does hit.&nbsp;</li><li>                  Applied Materials shares are&nbsp;<font color='red'>down 2.1%</font>.&nbsp; </li><li>Previously: <a href=\"https://seekingalpha.com/news/3331161-applied-materials-plus-3-percent-record-sales-drive-beats-doubled-dividend\" target=\"_blank\">Applied Materials +3% after record sales drive beats, doubled dividend</a> (Feb. 14)</li></ul><div class=\"tiny-share-widget\" data-id=\"3331510\" data-linked=\"Stifel raises Applied Materials target to 37% upside\" data-tweet=\"$AMAT - Stifel raises Applied Materials target to 37% upside https://seekingalpha.com/news/3331510-stifel-raises-applied-materials-target-to-37-upside?source=tweet\" data-url=\"https://seekingalpha.com/news/3331510-stifel-raises-applied-materials-target-to-37-upside\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:48 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>22&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331508\" data-ts=\"1518709466\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/THS\" target=\"_blank\">THS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331508-weak-guidance-sends-treehouse-foods-to-52-week-low\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Weak guidance sends TreeHouse Foods to 52-week low</a></h4><ul> <li>TreeHouse Foods (<a href='https://seekingalpha.com/symbol/THS' title='TreeHouse Foods, Inc.'>THS</a> <font color='red'>-11.7%</font>) falls after issuing disappointing full-year revenue <a href=\"https://seekingalpha.com/pr/17075631-treehouse-foods-inc-reports-fourth-quarter-2017-results-provides-2018-guidance-company\" target=\"_blank\">guidance</a>.</li> <li>The company expects full-year sales of $5.9B-$6.1B vs. $6.24B consensus. Treehouse's planned SKU reduction initiatives are a factor.</li> <li>CEO update: \"Although the retail grocery landscape continues to evolve, private label absolutely continues to be the right place to be within food and beverage. It will take some time for our TreeHouse 2020 initiatives to manifest themselves in our results. However, we are well on our way to simplifying, reshaping, and optimizing our manufacturing and distribution footprint so that we can be a more efficient and effective operating company going forward.\"</li> <li>Shares of TreeHouse dropped to a 52-week low of $36.35 earlier.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3331342-treehouse-foods-beats-0_09-beats-revenue\" target=\"_blank\">TreeHouse Foods beats by $0.09, beats on revenue</a> (Feb. 15)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3331394-treehouse-foods-announces-plans-close-facility-visalia-california\" target=\"_blank\">TreeHouse Foods announces plans to close facility in Visalia, California</a> (Feb. 15)</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3331508\" data-linked=\"Weak guidance sends TreeHouse Foods to 52-week low\" data-tweet=\"$THS - Weak guidance sends TreeHouse Foods to 52-week low https://seekingalpha.com/news/3331508-weak-guidance-sends-treehouse-foods-to-52-week-low?source=tweet\" data-url=\"https://seekingalpha.com/news/3331508-weak-guidance-sends-treehouse-foods-to-52-week-low\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:44 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331505\" data-ts=\"1518709094\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ABEO\" target=\"_blank\">ABEO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331505-abeona-rebounds-from-bearish-report-stoked-selloff-up-1\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Abeona rebounds from bearish report-stoked selloff, up 1%</a></h4><ul><li>Abeona Therapeutics (<a href='https://seekingalpha.com/symbol/ABEO' title='Abeona Therapeutics Inc.'>ABEO</a> <font color='green'>+0.9%</font>) is up on modestly higher volume. Shares were down over&nbsp;<font color='red'>8%</font>&nbsp;before recovering in apparent response to a <a href=\"https://moxreports.com/wp-content/uploads/2018/02/Abeona-Plunges-on-Data-Manipulation-2.pdf\" target=\"_blank\">bearish call</a> from MOX Reports.</li><li>MOX believes the fair value of ABEO shares is $4 - 6, representing 48 - 65% downside risk, citing questionable&nbsp; data on gene therapy ABO-101 for MPS IIIB.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3328929-abeonas-gene-therapy-candidate-sanfilippo-b-shows-encouraging-effect-first-patient-shares-12\" target=\"_blank\">Abeona's gene therapy candidate for Sanfilippo B shows encouraging effect in first patient; shares up 12%</a> (Feb. 7)</li></ul><div class=\"tiny-share-widget\" data-id=\"3331505\" data-linked=\"Abeona rebounds from bearish report-stoked selloff, up 1%\" data-tweet=\"$ABEO - Abeona rebounds from bearish report-stoked selloff, up 1% https://seekingalpha.com/news/3331505-abeona-rebounds-from-bearish-report-stoked-selloff-up-1?source=tweet\" data-url=\"https://seekingalpha.com/news/3331505-abeona-rebounds-from-bearish-report-stoked-selloff-up-1\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:38 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>54&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331506\" data-ts=\"1518708874\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ORCL\" target=\"_blank\">ORCL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331506-oracle-acquires-system-security-company\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Oracle acquires IT system security company</a></h4><ul><li>        Oracle (NYSE:<a href='https://seekingalpha.com/symbol/ORCL' title='Oracle Corporation'>ORCL</a>) will <a href=\"https://www.oracle.com/corporate/pressrelease/oracle-buys-zenedge-021518.html\" target=\"_blank\">acquire</a> IT system security company Zenedge.&nbsp;</li><li>           Zenedge&rsquo;s AI-powered mitigation products include Web Application Firewall and Distributed Denial of Service.&nbsp; </li><li>        Terms were not disclosed.&nbsp;</li><li>        Oracle shares are&nbsp;<font color='green'>up 1.1%</font>.&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3331506\" data-linked=\"Oracle acquires IT system security company\" data-tweet=\"$ORCL - Oracle acquires IT system security company https://seekingalpha.com/news/3331506-oracle-acquires-system-security-company?source=tweet\" data-url=\"https://seekingalpha.com/news/3331506-oracle-acquires-system-security-company\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:34 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331503\" data-ts=\"1518708408\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SEDG\" target=\"_blank\">SEDG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331503-solaredgeplus-22-after-sunny-earnings-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SolarEdge +22% after sunny earnings, guidance</a></h4><ul><li>SolarEdge Technologies (<a href='https://seekingalpha.com/symbol/SEDG' title='SolarEdge Technologies'>SEDG</a> <font color='green'>+21.5%</font>) skyrockets to an all-time high after reporting  <a href=\"https://seekingalpha.com/news/3331156-solaredge-plus-14-percent-easy-q4-beat-guides-q1-revenues-consensus\" target=\"_blank\">impressive Q4 results</a> and guidance following yesterday's close.</li><li>On its <a href=\"https://seekingalpha.com/article/4146912-solaredge-technologies-sedg-ceo-guy-sella-q4-2017-results-earnings-call-transcript\" target=\"_blank\">earnings conference call</a>, SEDG said its business is growing at a healthy rate and  management is staying focused on the bottom line, and it expanded gross margin by keeping ASPs stable and continuing its cost  reduction initiatives.</li><li>SEDG also said it is starting to see products from a Chinese manufacturer that recently introduced an optimizer but with a reduced set of  features and relatively high pricing in Australia; it believes the products have only basic functionality and lack communications features and a safety mechanism.</li><li>As a result, SEDG expects market penetration for the products will prove challenging, especially from U.S. and western European customers seeking quality products for rooftops and cautious of security concerns of PV systems and their effect on the electrical grid if not  properly secured against cyber-attacks.</li><li>Source:&nbsp;Briefing.com</li></ul><div class=\"tiny-share-widget\" data-id=\"3331503\" data-linked=\"SolarEdge +22% after sunny earnings, guidance\" data-tweet=\"$SEDG - SolarEdge +22% after sunny earnings, guidance https://seekingalpha.com/news/3331503-solaredgeplus-22-after-sunny-earnings-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3331503-solaredgeplus-22-after-sunny-earnings-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:26 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331494\" data-ts=\"1518708231\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MBRX\" target=\"_blank\">MBRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331494-moleculin-announces-major-breakthrough-in-cancer-treatment-shares-up-54\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Moleculin announces &quot;major breakthrough&quot; in cancer treatment; shares up 54%</a></h4><ul><li>Thinly traded nano cap Moleculin Biotech (<a href='https://seekingalpha.com/symbol/MBRX' title='Moleculin Biotech, Inc.'>MBRX</a> <font color='green'>+53.8%</font>) jumps out the gate on a whopping 27x surge in volume in response to its <a href=\"https://seekingalpha.com/pr/17075922-moleculin-announces-breakthrough-discovery-new-molecule-cancer-treatment\" target=\"_blank\">announcement </a>that preclinical tests have shown that it can control a process called \"ubiquitination\" to block the activated form of a protein called STAT3, a key oncogenic transcription factor. Inhibiting the formation of STAT3 prevents the start of unwanted gene transcription in cancer cells which controls the cancer.</li><li>The company's lead STAT3 inhibitor is WP1066.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3316291-fda-signs-early-stage-study-moleculins-wp1066-brain-tumors-shares-36-percent-premarket\" target=\"_blank\">FDA signs off on early-stage study of Moleculin's WP1066 in brain tumors; shares up 36% premarket</a> (Dec. 5, 2017)</li></ul><div class=\"tiny-share-widget\" data-id=\"3331494\" data-linked=\"Moleculin announces &quot;major breakthrough&quot; in cancer treatment; shares up 54%\" data-tweet=\"$MBRX - Moleculin announces &quot;major breakthrough&quot; in cancer treatment; shares up 54% https://seekingalpha.com/news/3331494-moleculin-announces-major-breakthrough-in-cancer-treatment-shares-up-54?source=tweet\" data-url=\"https://seekingalpha.com/news/3331494-moleculin-announces-major-breakthrough-in-cancer-treatment-shares-up-54\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:23 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331502\" data-ts=\"1518708024\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INPX\" target=\"_blank\">INPX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331502-inpixonminus-27-after-pricing-public-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Inpixon -27% after pricing public offering</a></h4><ul><li>        Inpixon (NASDAQ:<a href='https://seekingalpha.com/symbol/INPX' title='Inpixon'>INPX</a>) <a href=\"https://seekingalpha.com/filing/3882791\" target=\"_blank\">prices a public offering</a> with Class A and B Units expected to total about $45M.</li><li>               Class A Units will have shares of common stock, par value $0.001 per share, and warrants to purchase common stock.&nbsp;</li><li>               Class B Units will have shares of Series 3 convertible preferred stock (convertible to 426 common shares), par value $0.001 per share, and warrants to purchase common stock.&nbsp;</li><li>               Inpixon shares are&nbsp;<font color='red'>down 27%</font>. &nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3331502\" data-linked=\"Inpixon -27% after pricing public offering\" data-tweet=\"$INPX - Inpixon -27% after pricing public offering https://seekingalpha.com/news/3331502-inpixonminus-27-after-pricing-public-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3331502-inpixonminus-27-after-pricing-public-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:20 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331500\" data-ts=\"1518707853\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BBW\" target=\"_blank\">BBW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331500-on-build-bears-q4-beat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Build-A-Bear&#39;s Q4 beat</a></h4><ul><li>Build-A-Bear Workshop (<a href='https://seekingalpha.com/symbol/BBW' title='Build-A-Bear Workshop, Inc.'>BBW</a> <font color='green'>+12.8%</font>)&nbsp;reports comparable sales declined 8% in&nbsp;<a href=\"https://seekingalpha.com/pr/17075619-build-bear-workshop-inc-reports-fiscal-year-2017-pre-tax-income-guidance\" sasource=\"qp_sum_news_15\"target=\"_blank\">Q4</a>.</li><li>Comp sales fell 6.5% in North America and 13.1% in Europe.</li><li>Comparable e-commerce sales up 11.7% for the quarter.</li><li>Retail gross margin rate expanded 510 bps to 51.1%.</li><li>SG&amp;A expense rate improved 90 bps to 41.7%.</li><li>Number of franchised stores +10 Y/Y to 102.</li><li>Total company-owned retail stores +15 Y/Y to 361.</li><li><b>FY2018 Guidance</b>: Revenue: slightly positive growth; Diluted EPS: $0.53 to $0.57; Tax rate: 25% to 27%; Capex: $15M to $18M; D&amp;A: $16M to $17M.</li></ul><div class=\"tiny-share-widget\" data-id=\"3331500\" data-linked=\"More on Build-A-Bear&#39;s Q4 beat\" data-tweet=\"$BBW - More on Build-A-Bear&#39;s Q4 beat https://seekingalpha.com/news/3331500-on-build-bears-q4-beat?source=tweet\" data-url=\"https://seekingalpha.com/news/3331500-on-build-bears-q4-beat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:17 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331491\" data-ts=\"1518706844\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FMCC\" target=\"_blank\">FMCC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331491-tax-reform-leads-to-loss-treasury-draw-freddie-mac\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tax reform leads to loss/Treasury draw at Freddie Mac</a></h4><ul><li>The cut in tax rates forced a $5.4B writedown in Freddie's (<a href='https://seekingalpha.com/symbol/FMCC' title='Freddie Mac'>OTCQB:FMCC</a> <font color='red'>-4.1%</font>) DTA, and thus a Q4 loss of $2.9B. The company expects to draw $312M from Treasury to cover its net worth deficit.</li><li><a href=\"http://www.freddiemac.com/investors/financials/pdf/2017er-4q17_release.pdf\" target=\"_blank\">Full earnings release</a></li><li>Previously: <a href=\"https://seekingalpha.com/news/3331437-freddie-mac-reports-q4-results\" target=\"_blank\">Freddie Mac reports Q4 results</a> (Feb. 15)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3330941-fannie-mae-take-treasury-draw-q4-loss\" target=\"_blank\">Fannie Mae to take Treasury draw after Q4 loss</a> (Feb. 14)</li></ul><div class=\"tiny-share-widget\" data-id=\"3331491\" data-linked=\"Tax reform leads to loss/Treasury draw at Freddie Mac\" data-tweet=\"$FMCC - Tax reform leads to loss/Treasury draw at Freddie Mac https://seekingalpha.com/news/3331491-tax-reform-leads-to-loss-treasury-draw-freddie-mac?source=tweet\" data-url=\"https://seekingalpha.com/news/3331491-tax-reform-leads-to-loss-treasury-draw-freddie-mac\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:00 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331484\" data-ts=\"1518706196\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CBZ\" target=\"_blank\">CBZ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331484-cbiz-beats-estimates-in-q4\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CBIZ beats estimates in Q4</a></h4><ul><li>CBIZ (<a href='https://seekingalpha.com/symbol/CBZ' title='CBIZ, Inc.'>CBZ</a> <font color='green'>+7.4%</font>)&nbsp;reports same-unit revenue rose 3.9% in&nbsp;<a href=\"https://seekingalpha.com/pr/17075598-cbiz-reports-fourth-quarter-full-year-2017-results\" target=\"_blank\">Q4</a>.</li><li>Acquisition contributed $9.4M (5.2%) to the revenue in the quarter.</li><li>Segment revenue:&nbsp;Financial services: $118.79M (+15.1%); Employee services: $68.52M (+1%);&nbsp;National practices: $7.83M (+0.8%).</li><li>Gross margin rate squeezed 150 bps to 2.6%.</li><li>Adjusted EBITDA advanced 65.4% to $8.94M.</li><li><b>FY2018 Guidance</b>:&nbsp;Total revenue: +5% to +8%; Income from continuing operations: +12% to +14%;&nbsp;Diluted EPS: +13% to +17%; Adjusted EPS: +20%b to +24%; Weighted average share count: ~56M; Tax rate: ~25%.</li></ul><div class=\"tiny-share-widget\" data-id=\"3331484\" data-linked=\"CBIZ beats estimates in Q4\" data-tweet=\"$CBZ - CBIZ beats estimates in Q4 https://seekingalpha.com/news/3331484-cbiz-beats-estimates-in-q4?source=tweet\" data-url=\"https://seekingalpha.com/news/3331484-cbiz-beats-estimates-in-q4\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:49 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331482\" data-ts=\"1518706097\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MBVX\" target=\"_blank\">MBVX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331482-mabvax-to-reverse-split-shares-1-3-effective-tomorrow-shares-down-6\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MabVax to reverse split shares 1:3 effective tomorrow; shares down 6%</a></h4><ul><li>Aimed at regaining compliance with Nasdaq's $1 minimum bid price requirement, MabVax Therapeutics Holdings (<a href='https://seekingalpha.com/symbol/MBVX' title='MABVAX THERAPEUTICS HLDGS'>OTCPK:MBVX</a> <font color='red'>-6.1%</font>) will execute a 1:3 <a href=\"https://seekingalpha.com/pr/17075709-mabvax-therapeutics-schedules-previously-announced-1minus-3-reverse-stock-split-regain\" target=\"_blank\">reverse split</a> of its common stock after the close. Post-split trading will commence tomorrow, February 16, at the open.</li></ul><div class=\"tiny-share-widget\" data-id=\"3331482\" data-linked=\"MabVax to reverse split shares 1:3 effective tomorrow; shares down 6%\" data-tweet=\"$MBVX $MBVXQ - MabVax to reverse split shares 1:3 effective tomorrow; shares down 6% https://seekingalpha.com/news/3331482-mabvax-to-reverse-split-shares-1-3-effective-tomorrow-shares-down-6?source=tweet\" data-url=\"https://seekingalpha.com/news/3331482-mabvax-to-reverse-split-shares-1-3-effective-tomorrow-shares-down-6\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:48 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331480\" data-ts=\"1518705678\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HIIQ\" target=\"_blank\">HIIQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331480-health-insurance-innovations-cleared-to-business-in-florida-shares-up-11\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Health Insurance Innovations cleared to do business in Florida; shares up 11%</a></h4><ul><li>The Florida Office of Insurance Regulation has <a href=\"https://www.sec.gov/Archives/edgar/data/1561387/000149315218002137/form8-k.htm\" target=\"_blank\">granted </a>a Certificate of Authority to Health Insurance Innovations (<a href='https://seekingalpha.com/symbol/HIIQ' title='Health Insurance Innovations'>HIIQ</a> <font color='green'>+11.1%</font>) subsidiary Health Plan Intermediaries Holdings, LLC &#40;HPIH&#41;&nbsp;allowing it to conduct business in the state as a third-party insurance administrator.</li><li>The consent order included a $140K fine due to HPIH doing business in Florida prior to submitting its application in October 2017.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3297335-health-insurance-innovations-progressing-tpa-license-florida-shares-4-percent-guidance-update\" target=\"_blank\">Health Insurance Innovations progressing on TPA license in Florida; shares up 4% after guidance update</a> (Sept. 25, 2017)</li></ul><div class=\"tiny-share-widget\" data-id=\"3331480\" data-linked=\"Health Insurance Innovations cleared to do business in Florida; shares up 11%\" data-tweet=\"$HIIQ - Health Insurance Innovations cleared to do business in Florida; shares up 11% https://seekingalpha.com/news/3331480-health-insurance-innovations-cleared-to-business-in-florida-shares-up-11?source=tweet\" data-url=\"https://seekingalpha.com/news/3331480-health-insurance-innovations-cleared-to-business-in-florida-shares-up-11\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:41 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331475\" data-ts=\"1518705040\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AXON\" target=\"_blank\">AXON</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331475-axovant-to-restructure-cut-staff\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Axovant to restructure, cut staff</a></h4><ul><li>Axovant Sciences (NASDAQ:<a href='https://seekingalpha.com/symbol/AXON' title='Axovant Sciences'>AXON</a>) <a href=\"https://www.sec.gov/Archives/edgar/data/1636050/000110465918009783/a18-6178_18k.htm\" target=\"_blank\">reports </a>that it has initiated a restructuring program that includes a reduction in headcount. It expects to complete the layoffs and transfers and record a $1.5M charge in fiscal Q3. Management says the move will save $6M - 8M in annualized operating costs, although partially offset by the costs of outsourcing certain services.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3330103-axovant-shakes-management-ceo-coo\" target=\"_blank\">Axovant shakes up management, CEO and COO out</a> (Feb. 12)</li></ul><div class=\"tiny-share-widget\" data-id=\"3331475\" data-linked=\"Axovant to restructure, cut staff\" data-tweet=\"$AXON $AXON-OLD - Axovant to restructure, cut staff https://seekingalpha.com/news/3331475-axovant-to-restructure-cut-staff?source=tweet\" data-url=\"https://seekingalpha.com/news/3331475-axovant-to-restructure-cut-staff\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:30 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331473\" data-ts=\"1518704865\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CVE\" target=\"_blank\">CVE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331473-cenovusplus-4-earnings-jump-production-nearly-doubles\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cenovus +4% as earnings jump, production nearly doubles</a></h4><ul>     <li>Cenovus Energy (NYSE:<a href='https://seekingalpha.com/symbol/CVE' title='Cenovus Energy, Inc.'>CVE</a>) <font color='green'>+3.9%</font> premarket as <a href=\"https://seekingalpha.com/news/3331305-cenovus-energy-eps-0_42\" target=\"_blank\">Q4 earnings</a> jumped to $620M, or $0.50/share, from $91M, or $0.11/share, in the year-ago  period.</li>     <li>CVE says total Q4 production was 554.6K boe/day, up 96% from 282.7K boe/day a year ago, largely <a href=\"https://www.reuters.com/article/us-cenovus-results/canadas-cenovus-energy-posts-jump-in-quarterly-profit-idUSKCN1FZ19H\" target=\"_blank\">helped by production</a> from its Christina Lake and Foster Creek oil sands operations in Alberta.</li>     <li>At year-end 2017, CVE says it had total proved reserves of 5.2B boe, up 96% Y/Y, and proved bitumen reserves rose 103% to 4.8B barrels.</li><li>Based on the evaluation of its bitumen reserves, CVE estimates future capital costs to develop its remaining proved undeveloped bitumen reserves fell to ~C$7/bbl in 2017 vs. ~C$8/bbl the previous year.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3331473\" data-linked=\"Cenovus +4% as earnings jump, production nearly doubles\" data-tweet=\"$CVE - Cenovus +4% as earnings jump, production nearly doubles https://seekingalpha.com/news/3331473-cenovusplus-4-earnings-jump-production-nearly-doubles?source=tweet\" data-url=\"https://seekingalpha.com/news/3331473-cenovusplus-4-earnings-jump-production-nearly-doubles\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:27 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>68&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331470\" data-ts=\"1518704475\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MBRX\" target=\"_blank\">MBRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331470-premarket-gainers-of-9-05-02-15-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers as of 9:05 am (02/15/2018)</a></h4><ul>     <li><a href='https://seekingalpha.com/symbol/MBRX' title='Moleculin Biotech, Inc.'>MBRX</a> <font color='green'>+48%</font>&nbsp;on major <a href=\"https://seekingalpha.com/pr/17075922-moleculin-announces-breakthrough-discovery-new-molecule-cancer-treatment\" target=\"_blank\">breakthrough</a> to develop a new cancer treatment.</li>     <li>ARGS <font color='green'>+22%</font>&nbsp;on issuance of&nbsp;U.S.&nbsp;patent covering the strain-independent amplification of human immunodeficiency virus.</li>     <li><a href='https://seekingalpha.com/symbol/AMAG' title='AMAG Pharmaceuticals, Inc.'>AMAG</a>&nbsp;<font color='green'>+19%</font>&nbsp;as FDA <a href=\"https://seekingalpha.com/news/3331373-fda-oks-amag-pharmas-makena-subcutaneous-auto-injector-shares-16-percent-premarket\" target=\"_blank\">grants</a> AMAG Pharma's Makena subcutaneous auto-injector.</li>     <li><a href='https://seekingalpha.com/symbol/SEDG' title='SolarEdge Technologies'>SEDG</a> <font color='green'>+17%</font>&nbsp;on Q4 <a href=\"https://seekingalpha.com/news/3331134-solaredge-technologies-beats-0_20-beats-revenue\" target=\"_blank\">result</a>.</li>     <li><a href='https://seekingalpha.com/symbol/TRIP' title='TripAdvisor Inc.'>TRIP</a> <font color='green'>+15%</font>&nbsp;on Q4&nbsp;<a href=\"https://seekingalpha.com/news/3331145-tripadvisor-eps-0_06-beats-revenue\" target=\"_blank\">result</a>.</li>     <li><a href='https://seekingalpha.com/symbol/ATRS' title='Antares Pharma Inc.'>ATRS</a> <font color='green'>+14%</font>&nbsp;as FDA&nbsp;<a href=\"https://seekingalpha.com/news/3331373-fda-oks-amag-pharmas-makena-subcutaneous-auto-injector-shares-16-percent-premarket\" target=\"_blank\">grants</a>&nbsp;AMAG Pharma's Makena subcutaneous auto-injector.</li>     <li><a href='https://seekingalpha.com/symbol/SHLM' title='A. Schulman, Inc.'>SHLM</a> <font color='green'>+10%</font>&nbsp;on being <a href=\"https://seekingalpha.com/news/3331414-lyondellbasell-buy-schulman-2_25b-deal\" target=\"_blank\">acquired</a> by LyondellBasell (NYSE:<a href='https://seekingalpha.com/symbol/LYB' title='LyondellBasell Industries N.V.'>LYB</a>).</li>     <li><a href='https://seekingalpha.com/symbol/TEVA' title='Teva Pharmaceutical Industries Limited'>TEVA</a> <font color='green'>+9%</font>&nbsp;on Berkshire <a href=\"https://seekingalpha.com/news/3331456-teva-set-bullish-day-berkshire-investment-shares-9-percent-premarket\" target=\"_blank\">investment</a>.</li>     <li><a href='https://seekingalpha.com/symbol/OMER' title='Omeros Corporation'>OMER</a> <font color='green'>+8%</font>&nbsp;as OMS721 <a href=\"https://seekingalpha.com/news/3331427-omeros-oms721-shows-treatment-effect-mid-stage-hct-tma-study-shares-ahead-10-percent\" target=\"_blank\">shows</a> treatment effect in mid-stage HCT-TMA study.</li>     <li><a href='https://seekingalpha.com/symbol/AVP' title='Avon Products, Inc.'>AVP</a> <font color='green'>+8%</font>&nbsp;on Q4&nbsp;<a href=\"https://seekingalpha.com/news/3331331-avon-products-beats-0_05-misses-revenue\" target=\"_blank\">result</a>.</li>     <li><a href='https://seekingalpha.com/symbol/CTL' title='CenturyLink, Inc.'>CTL</a> <font color='green'>+8%</font>&nbsp;on Q4&nbsp;<a href=\"https://seekingalpha.com/news/3331171-centurylink-eps-1_26\" target=\"_blank\">result</a>.</li>     <li><a href='https://seekingalpha.com/symbol/MARA' title='Marathon Patent Group, Inc.'>MARA</a> <font color='green'>+8%</font>&nbsp;on <a href=\"https://seekingalpha.com/pr/17075929-marathon-patent-group-expands-cryptocurrency-mining-operations-opening-second-facility-canada\" target=\"_blank\">expanding</a> cryptocurrency mining operations.</li>     <li><a href='https://seekingalpha.com/symbol/YNDX' title='Yandex N.V.'>YNDX</a> <font color='green'>+7%</font>&nbsp;on Q4&nbsp;<a href=\"https://seekingalpha.com/news/3331326-yandex-misses-0_03-beats-revenue\" target=\"_blank\">result</a>.</li>     <li><a href='https://seekingalpha.com/symbol/CSCO' title='Cisco Systems, Inc.'>CSCO</a> <font color='green'>+7%</font>&nbsp;on Q2&nbsp;<a href=\"https://seekingalpha.com/news/3331121-cisco-beats-0_04-beats-revenue\" target=\"_blank\">result</a>.</li>     <li><a href='https://seekingalpha.com/symbol/CARA' title='Cara Therapeutics Inc.'>CARA</a> <font color='green'>+7%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/RIOT' title='Riot Blockchain, Inc.'>RIOT</a> <font color='green'>+6%&nbsp;</font>on&nbsp;<a href=\"https://seekingalpha.com/pr/17075919-riot-blockchain-enters-definitive-agreement-acquisition-3800-s9-bitcoin-miners\" target=\"_blank\">entering</a> into a definitive agreement to acquire additional cryptocurrency mining equipment.</li>     <li><a href='https://seekingalpha.com/symbol/OSTK' title='Overstock.com, Inc.'>OSTK</a> <font color='green'>+5%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/DPW' title='DPW Holdings, Inc.'>DPW</a> <font color='green'>+5%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3331470\" data-linked=\"Premarket Gainers as of 9:05 am (02/15/2018)\" data-tweet=\"$MBRX $MBRX $ARGSQ - Premarket Gainers as of 9:05 am (02/15/2018) https://seekingalpha.com/news/3331470-premarket-gainers-of-9-05-02-15-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3331470-premarket-gainers-of-9-05-02-15-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:21 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331462\" data-ts=\"1518703852\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INPX\" target=\"_blank\">INPX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331462-premarket-losers-of-9-05-2-15-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Losers as of 9:05 am (2/15/2018)</a></h4><ul>     <li><a href='https://seekingalpha.com/symbol/INPX' title='Inpixon'>INPX</a>&nbsp;<font color='red'>-27%</font>&nbsp;on <a href=\"https://seekingalpha.com/pr/17075381-inpixon-launches-public-offering\" target=\"_blank\">launching</a> public offering.</li><li><a href='https://seekingalpha.com/symbol/NTAP' title='NetApp, Inc.'>NTAP</a>&nbsp;<font color='red'>-12%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3331114-netapp-beats-0_08-beats-revenue\" target=\"_blank\">Q3 earnings</a>.</li><li><a href='https://seekingalpha.com/symbol/ATRA' title='Atara Biotherapeutics'>ATRA</a>&nbsp;<font color='red'>-10%</font>&nbsp;on analyst <a href=\"https://seekingalpha.com/news/3331444-premarket-analyst-action-healthcare\" target=\"_blank\">downgrade</a>.</li><li><a href='https://seekingalpha.com/symbol/SPWR' title='SunPower Corporation'>SPWR</a>&nbsp;<font color='red'>-9%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3331122-sunpower-beats-0_14-beats-revenue\" target=\"_blank\">Q4 earnings</a>.</li><li><a href='https://seekingalpha.com/symbol/THS' title='TreeHouse Foods, Inc.'>THS</a>&nbsp;<font color='red'>-9%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3331342-treehouse-foods-beats-0_09-beats-revenue\" target=\"_blank\">Q4 earnings</a>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3331462\" data-linked=\"Premarket Losers as of 9:05 am (2/15/2018)\" data-tweet=\"$INPX $INPX $NTAP - Premarket Losers as of 9:05 am (2/15/2018) https://seekingalpha.com/news/3331462-premarket-losers-of-9-05-2-15-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3331462-premarket-losers-of-9-05-2-15-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:10 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331461\" data-ts=\"1518703832\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CDK\" target=\"_blank\">CDK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331461-cdkminus-5_4-on-reports-of-buyout-pause\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CDK -5.4% on reports of buyout pause</a></h4><ul><li>        CDK (NYSEARCA:<a href='https://seekingalpha.com/symbol/CDK' title='CDK Global, Inc'>CDK</a>) shares&nbsp;<font color='red'>drop 5.4%</font>&nbsp;on reports that firms paused work on the company&rsquo;s buyout.</li><li>               Source: Bloomberg First Word, citing Dealreporter.&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3330016-cdk-plus-9_4-percent-chatter-carlyle-silver-lake-near-buyout-deal\" target=\"_blank\">CDK +9.4% on chatter Carlyle, Silver Lake are near buyout deal</a> (Feb. 9)</li></ul><div class=\"tiny-share-widget\" data-id=\"3331461\" data-linked=\"CDK -5.4% on reports of buyout pause\" data-tweet=\"$CDK - CDK -5.4% on reports of buyout pause https://seekingalpha.com/news/3331461-cdkminus-5_4-on-reports-of-buyout-pause?source=tweet\" data-url=\"https://seekingalpha.com/news/3331461-cdkminus-5_4-on-reports-of-buyout-pause\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:10 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331459\" data-ts=\"1518703641\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AAN\" target=\"_blank\">AAN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331459-aaron-higher-on-earnings-beat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Aaron higher on earnings beat</a></h4><ul><li>Aaron's (NYSE:<a href='https://seekingalpha.com/symbol/AAN' title='Aaron&#39;s Inc.'>AAN</a>) reports same-store revenue fell 5.4% in <a href=\"https://seekingalpha.com/pr/17075702-aarons-inc-reports-fourth-quarter-year-end-2017-results\" target=\"_blank\">Q4</a>.</li><li>Segment revenues:&nbsp;Aaron's Business&nbsp;: $446.9M (-3.6%); Progressive:&nbsp;$428.52M (+32.3%); DAMI: $9.3M (+24%).</li><li>Adjusted EBITDA expanded 21.7% to $89.88M.</li><li>Customer counts on a same-store basis down 4%.</li><li>Total Aaron's customers at the end of the quarter up 1% to 983K.</li><li>Total store count -6 Q/Q to 1,175.</li><li><b>FY2018 Guidance</b>:&nbsp;Total revenues: $3.68B to $3.89B;&nbsp;Aaron's Business revenue: $1.7B to $1.8B;&nbsp;Progressive revenue: $1.95B to $2.05B; DAMI revenue: ~$30M to $40M; Adjusted EBITDA: $380M to $413M;&nbsp;Aaron's Business EBITDA : $170M to $185M;&nbsp;Progressive EBITDA: $215M to $230M; Diluted EPS: $2.90 to $3.20; Adjusted Diluted EPS: $3.20 to $3.50.</li><li>AAN&nbsp;<font color='green'>+6.57%</font>&nbsp;premarket.</li></ul><div class=\"tiny-share-widget\" data-id=\"3331459\" data-linked=\"Aaron higher on earnings beat\" data-tweet=\"$AAN - Aaron higher on earnings beat https://seekingalpha.com/news/3331459-aaron-higher-on-earnings-beat?source=tweet\" data-url=\"https://seekingalpha.com/news/3331459-aaron-higher-on-earnings-beat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:07 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331458\" data-ts=\"1518703616\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NBL\" target=\"_blank\">NBL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331458-noble-energy-unveils-750m-share-buyback-plan-gulf-of-mexico-asset-sale\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Noble Energy unveils $750M share buyback plan, Gulf of Mexico asset sale</a></h4><ul>     <li>Noble Energy (NYSE:<a href='https://seekingalpha.com/symbol/NBL' title='Noble Energy, Inc.'>NBL</a>)&nbsp;<font color='green'>+2.3%</font> premarket after announcing a <a href=\"https://seekingalpha.com/pr/17075928-noble-energy-announces-750-million-share-repurchase-program\" target=\"_blank\">$750M share repurchase plan</a> and an agreement to sell its deepwater Gulf of Mexico assets to Fieldwood Energy for $710M.</li>     <li>NBL says the sale of the Gulf of Mexico business  is the last major step in its portfolio transformation, and the company will focus on U.S. onshore and the eastern Mediterranean, areas it says \"will rapidly grow our cash flows and margins.\"</li>     <li>NBL says it will use the proceeds from the sell to partly finance the share buyback program, to be executed through 2020.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3331458\" data-linked=\"Noble Energy unveils $750M share buyback plan, Gulf of Mexico asset sale\" data-tweet=\"$NBL - Noble Energy unveils $750M share buyback plan, Gulf of Mexico asset sale https://seekingalpha.com/news/3331458-noble-energy-unveils-750m-share-buyback-plan-gulf-of-mexico-asset-sale?source=tweet\" data-url=\"https://seekingalpha.com/news/3331458-noble-energy-unveils-750m-share-buyback-plan-gulf-of-mexico-asset-sale\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:06 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331457\" data-ts=\"1518703584\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ALSN\" target=\"_blank\">ALSN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331457-margin-miss-clips-allison-transmission\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Margin miss clips Allison Transmission</a></h4><ul> <li>Allison Transmission (NYSE:<a href='https://seekingalpha.com/symbol/ALSN' title='Allison Transmission'>ALSN</a>) is in reverse in early trading despite topping estimates on both lines of its Q4 report.</li> <li>Goldman Sachs notes that underneath the hood the company fell short of expectations on its margin rate and adjusted EBITDA.</li> <li>GS keeps a Neutral rating and $44 price target on Allison.</li> <li>Sources: CNBC and Bloomberg</li><li>Previously: <a href=\"https://seekingalpha.com/news/3331148-allison-transmission-beats-0_88-beats-revenue\" target=\"_blank\">Allison Transmission beats by $0.88, beats on revenue</a> (Feb. 14)</li> <li>ALSN <font color='red'>-2.25%</font> premarket to $41.30.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3331457\" data-linked=\"Margin miss clips Allison Transmission\" data-tweet=\"$ALSN - Margin miss clips Allison Transmission https://seekingalpha.com/news/3331457-margin-miss-clips-allison-transmission?source=tweet\" data-url=\"https://seekingalpha.com/news/3331457-margin-miss-clips-allison-transmission\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:06 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331456\" data-ts=\"1518703357\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TEVA\" target=\"_blank\">TEVA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331456-teva-set-for-bullish-day-on-berkshire-investment-shares-up-9-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Teva set for bullish day on Berkshire investment, shares up 9% premarket</a></h4><ul><li>Teva Pharmaceutical Industries (NYSE:<a href='https://seekingalpha.com/symbol/TEVA' title='Teva Pharmaceutical Industries Limited'>TEVA</a>) is set for an opening gap on the news that Warren Buffett's Berkshire Hathaway has acquired a stake in the drug maker.</li><li>A timely bonus for investors is a <a href=\"https://seekingalpha.com/article/4146529-behind-idea-tevas-tribulations-podcast?ifp=0&amp;v=1518612300\" target=\"_blank\">podcast</a> on Teva from SA's Daniel Shvartsman and Mike Taylor published yesterday.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3331151-teva-7-percent-hours-berkshire-stake\" target=\"_blank\">Teva up 7% after hours on Berkshire stake</a> (Feb. 14)</li></ul><div class=\"tiny-share-widget\" data-id=\"3331456\" data-linked=\"Teva set for bullish day on Berkshire investment, shares up 9% premarket\" data-tweet=\"$TEVA - Teva set for bullish day on Berkshire investment, shares up 9% premarket https://seekingalpha.com/news/3331456-teva-set-for-bullish-day-on-berkshire-investment-shares-up-9-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3331456-teva-set-for-bullish-day-on-berkshire-investment-shares-up-9-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:02 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331453\" data-ts=\"1518703263\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AVP\" target=\"_blank\">AVP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331453-new-avon-ceo-rallies-troops-after-earnings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">New Avon CEO rallies the troops after earnings</a></h4><ul> <li>Avon Products (NYSE:<a href='https://seekingalpha.com/symbol/AVP' title='Avon Products, Inc.'>AVP</a>) rallies after knocking out a Q4 profit beat on revenue of $1.57B.</li> <li>The company's recorded a gross margin rate of 61.1% of sales to top the consensus estimate for a 60.8% mark and last year's level of 60.3%. A favorable product mix helped boost the company's margin rate during the quarter. Adjusted operating margin rose 250 bps to 9.8% of sales.</li> <li>New CEO Jan Zijderveld makes his first appearance in an Avon earnings report. \"Very few brands have Avon's brand recognition, extensive global reach and operate in attractive beauty channel categories,\" says the recently hired exec. \"In a world where trust in companies is becoming a scarce commodity, our Representatives' relationships with their consumers has never been more relevant or compelling,\" he adds.</li> <li>AVP <font color='green'>+10.13%</font> premarket to $2.50 vs. a 52-week trading range of $1.85 to $5.41.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3331331-avon-products-beats-0_05-misses-revenue\" target=\"_blank\">Avon Products beats by $0.05, misses on revenue</a> (Feb. 15)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3331453\" data-linked=\"New Avon CEO rallies the troops after earnings\" data-tweet=\"$AVP - New Avon CEO rallies the troops after earnings https://seekingalpha.com/news/3331453-new-avon-ceo-rallies-troops-after-earnings?source=tweet\" data-url=\"https://seekingalpha.com/news/3331453-new-avon-ceo-rallies-troops-after-earnings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:01 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331447\" data-ts=\"1518702729\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ECA\" target=\"_blank\">ECA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331447-encana-rises-after-strong-q4-results-share-buyback-plan\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Encana rises after strong Q4 results, share buyback plan</a></h4><ul>     <li>Encana (NYSE:<a href='https://seekingalpha.com/symbol/ECA' title='Encana Corporation'>ECA</a>)&nbsp;<font color='green'>+2.2%</font> premarket after reporting <a href=\"https://seekingalpha.com/news/3331303-encana-net-income-114m\" target=\"_blank\">Q4 operating earnings</a> of $114M vs. $85M in the year-ago quarter and announcing plans to spend up to $400M to repurchase up to 35M shares over the next 12 months through a normal course issuer bid.</li>     <li>ECA says Q4 total production rose 4% Y/Y to average 335.2K boe/day, with core assets contributing 93% and rising 31% Y/Y, but full-year total production fell 11% to 313.2K boe/day, with core assets contributing 83%.</li><li>Non-GAAP cash flow margin rose 81% Y/Y to $11.75/boe, significantly exceeding the company's original 2017 target of  $10/boe.</li>     <li>ECA says Q4 Permian production of 82.6K boe/day beat its original 2017 target of 75K boe/day, and Q4 Montney liquids production more than doubled from  the year-ago quarter to 29K bbl/day.</li>     <li>ECA expects 2018 capital spending of $1.8B-$1.9B, with ~70% focused on growing oil production from the Permian and high-margin condensate production in the Montney.</li>     <li>The company forecasts 2018 total production of 360K-380K boe/day, with liquids production of 165K-175K bbl/day.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3331447\" data-linked=\"Encana rises after strong Q4 results, share buyback plan\" data-tweet=\"$ECA - Encana rises after strong Q4 results, share buyback plan https://seekingalpha.com/news/3331447-encana-rises-after-strong-q4-results-share-buyback-plan?source=tweet\" data-url=\"https://seekingalpha.com/news/3331447-encana-rises-after-strong-q4-results-share-buyback-plan\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:52 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331445\" data-ts=\"1518702693\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CRM\" target=\"_blank\">CRM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331445-jefferies-upgrades-salesforce-to-21-upside-sharesplus-2_7\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Jefferies upgrades Salesforce to 21% upside; shares +2.7%</a></h4><ul><li>        Jefferies <a href=\"https://www.cnbc.com/2018/02/15/salesforce-shares-rise-after-jefferies-upgrades-stock-predicts-20-percent-rally.html\" target=\"_blank\">upgrades</a> Salesforce (NYSE:<a href='https://seekingalpha.com/symbol/CRM' title='Salesforce.com, Inc.'>CRM</a>) from Hold to Buy and increases the price target from $97 to $132, a 21% upside to yesterday&rsquo;s close.</li><li>               Analyst John DiFucci writes, &ldquo;We see many engines of growth for the company over the long-term as it continues to expand in multiple segments. The company&rsquo;s customer-centric and vertical-focused approach to enterprise penetration has been key to its success, which we expect to continue into the future.&rdquo;&nbsp;</li><li>               DiFucci estimates that new subscription annualized contractual value was likely robust across regions and should result in a 23% billings growth.&nbsp;</li><li>               DiFucci says the firm&rsquo;s surveys show Microsoft becoming less of a competitive pressure for Salesforce in the most recent quarter.&nbsp;</li><li>               Salesforce shares are&nbsp;<font color='green'>up 2.7%</font>&nbsp;premarket.&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3331445\" data-linked=\"Jefferies upgrades Salesforce to 21% upside; shares +2.7%\" data-tweet=\"$CRM - Jefferies upgrades Salesforce to 21% upside; shares +2.7% https://seekingalpha.com/news/3331445-jefferies-upgrades-salesforce-to-21-upside-sharesplus-2_7?source=tweet\" data-url=\"https://seekingalpha.com/news/3331445-jefferies-upgrades-salesforce-to-21-upside-sharesplus-2_7\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:51 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3331444\" data-ts=\"1518702666\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MRNS\" target=\"_blank\">MRNS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3331444-premarket-analyst-action-healthcare\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket analyst action - healthcare</a></h4><ul><li>Marinus Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/MRNS' title='Marinus Pharmaceuticals'>MRNS</a>) initiated with Buy rating and $33 (443% upside) price target at H.C. Wainwright. Shares up&nbsp;<font color='green'>4%</font>&nbsp;premarket.</li><li>Arsanis (NASDAQ:<a href='https://seekingalpha.com/symbol/ASNS' title='Arsanis, Inc.'>ASNS</a>) initiated with Overweight rating with a $26 (111% upside) price target at Cantor Fitzgerald.</li><li>PolarityTE (COOL) initiated with Overweight rating and $70 (245% upside) price target at Cantor. Shares up&nbsp;<font color='green'>17%</font>&nbsp;premarket.</li><li>Adverum Biotechnologies (NASDAQ:<a href='https://seekingalpha.com/symbol/ADVM' title='Adverum Biotechnologies, Inc.'>ADVM</a>) resumed with Overweight rating and $12 (85% upside) price target at Piper Jaffray. Shares up&nbsp;<font color='green'>5%</font>&nbsp;premarket.</li><li>Henry Schein (NASDAQ:<a href='https://seekingalpha.com/symbol/HSIC' title='Henry Schein, Inc.'>HSIC</a>) resumed with Neutral rating and $77 (13% upside) price target at JPMorgan. Shares down&nbsp;<font color='red'>1%&nbsp;</font>premarket.</li><li>Atara Biotherapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/ATRA' title='Atara Biotherapeutics'>ATRA</a>) downgraded to Sell at Citigroup. Shares down&nbsp;<font color='red'>6%&nbsp;</font>premarket.</li></ul><div class=\"tiny-share-widget\" data-id=\"3331444\" data-linked=\"Premarket analyst action - healthcare\" data-tweet=\"$MRNS $MRNS $XFOR - Premarket analyst action - healthcare https://seekingalpha.com/news/3331444-premarket-analyst-action-healthcare?source=tweet\" data-url=\"https://seekingalpha.com/news/3331444-premarket-analyst-action-healthcare\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:51 AM </div></div></li>","count":75,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}